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Proteins provide evidence that a given gene is expressed, and machine learning
algorithms can be applied to various proteomics problems in order to gain information
about the underlying biology. This dissertation applies machine learning algorithms to
proteomics data in order to predict whether or not a given peptide is observable by mass
spectrometry, whether a given peptide can serve as a cell penetrating peptide, and then
utilizes the peptides observed through mass spectrometry to aid in the structural
annotation of the chicken genome. Peptides observed by mass spectrometry are used to
identify proteins, and being able to accurately predict which peptides will be seen can
allow researchers to analyze to what extent a given protein is observable. Cell
penetrating peptides can possibly be utilized to allow targeted small molecule delivery
across cellular membranes and possibly serve a role as drug delivery peptides. Peptides
and proteins identified through mass spectrometry can help refine computational gene
models and improve structural genome annotations.
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CHAPTER I
INTRODUCTION

With the availability and advancement of rapid genome sequencing technology,
an abundance of genomic sequence information is becoming available. In addition, highthroughput proteomics techniques rapidly generate large volumes of data useful for both
protein identification and determining protein expression. Since the amount of biological
data available for research in the biological sciences is growing rapidly, new
experimental and computational methods and tools must be developed to transform data
into information. Proteomics focuses on the study of proteins and peptides and the
patterns of their expression and regulation within a given organism. Proteins serve as the
building blocks of life, and can serve as both structural entities and biochemical catalysts
within living cells. Given the rapidly increasing volume of proteomics data,
computational techniques for mining and analyzing the data are needed. Machine
learning, a subfield within artificial intelligence, is routinely used in computational
biology to derive models from large data sets and use these models to predict behavior of
an experimental system.
This dissertation applies machine learning and other computational techniques 1)
to predict the detectability of peptides using mass spectrometry, 2) to predict the cell
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penetration potential of peptides, and 3) to assist in the structural genome annotation of
the genomes through a process termed proteogenomic mapping [1].
The first problem, the prediction of peptides detectable by mass spectrometry
using machine learning algorithms, specifically examines the use of neural networks in
the prediction of detectablility. Published datasets from chicken bursa and lymphoma
proteomics experiments were used as training and test sets for the machine learning
classifiers. This work has been published in BMC Bioinformatics[2].
The second problem, the prediction of peptides capable of penetrating cellular
membranes using machine learning algorithms, adapts the features from the prediction of
MS peptide dectectability and utilizes these properties in conjunction with support vector
machines to predict cell penetration potential. A literature search of known cellpenetrating peptides, along with known cell-penetrating peptides available from
commercial vendors was used to create data sets for training and testing the support
vector machines. A subset of peptides predicted to be cell-penetrating and nonpenetrating were synthesized and utilized for experimental validation of the classifier
using avian eukaryotic tissue culture systems in conjunction with fluorescence
microscopy and fluorescent quantitative uptake analysis. This work has been submitted
for publication in PLOS Computational Biology and the manuscript is in revision.
The third problem, using peptides observed by mass spectrometry to assist in the
structural annotation of genomes through proteogenomic mapping, has been investigated
using the Gallus gallus genome. Proteogenomic mapping uses peptides detected from
high-throughput mass spectrometry to compliment traditional genome annotation
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methods based on computational gene prediction and EST/cDNA libraries. Mapping the
peptides to the genome, provides evidence for new functional genomic units that
traditional methods often fail to identify. Recent findings from the ENCyclopedia Of
DNA Elements (ENCODE) project [3] show that the human genome is more active than
previously believed, with a significant portions of the genome being pervasively
transcribed. Given this pervasive transcription, it is likely that some of these transcripts
are translated into protein. Proteogenomic mapping can reveal which of these transcripts
are expressed at the protein level. A paper describing the proteogenomic pipeline has
been accepted for publication in BMC Bioinformatics. A paper describing the results of
proteogenomic mapping with chicken serum is in preparation.
The remainder of this chapter briefly introduces the three problems in more detail
and provides an overview of the relevant literature. More in-depth discussions of the
relevant literature are included in subsequent chapters along with the research approaches
and methodologies, and results.

Prediction of Peptide Properties
The primary amino acid sequences of peptides have been used to calculate and
infer a number of properties of peptides such as mass, isoelectric point, secondary
structure , etc.. These properties can, in turn, be used by machine learning algorithms to
construct classifiers to predict additional peptide properties such as the observability of a
given peptide using mass spectrometry or the cell penetrating potential of a given peptide.

3

Peptides Observability by Mass Spectrometry
In high-throughput non-electrophoretic proteomics, complex mixtures of proteins
are subjected to proteolytic digestion with an enzyme such as trypsin before the
fragments are separated by liquid chromatography (LC) and analyzed by tandem mass
spectrometry. However, for a particular protein, only a portion of the peptides are
actually observed experimentally and the set of peptides that are observed from a single
protein can vary substantially from one experiment to another. A number of factors
contribute to lack of detection of some peptides and to variations in the peptides detected
from one experiment to another. These include incomplete proteolytic digestion, small
size, poor binding or elution from the type of LC column used, mass range limitations of
the mass spectrometer, bias for detecting peptides with an intense MS signal in mixtures,
the phenomenon of ―ion suppression‖, the charge prior to ionization, and non-covalent
interactions between peptides in the gas phase while in the mass spectrometer [4]. There
are also substantial differences in the peptides observed due to experimental variations in
protein extraction and/or solublization methods, tissue types, prefractionation, LC
separation conditions, and differences between gradients even when the same LC
separation conditions are used. Furthermore, different databases, different search
software and even different versions of the same software also influence which peptides
are detected.
We refer to peptides that can be detected as ―flyable‖. The fact that most proteins
in a complex mixture are represented by only a small number of proteolytic peptides
presents several difficulties for proteomics researchers [5]. These problems include
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assessment of the level of confidence in protein identifications [6], determining the
peptide coverage of proteins [7], determining if ―missing‖ proteins are potentially
observable [8, 9], and using peptide observability as an adjustment factor for protein
quantification based on observed peptides [7, 10]. Recently reported methods for
predicting peptide observability have been based on large training datasets from multiple
experiments dealing with a single organism [7, 10]. However, because the observability
of peptides depends not only on the properties of the peptides themselves but also on
specific experimental, instrumental, and analytical procedures, we contend that it is
necessary to provide a method for predicting peptide observability for a specific
experimental set at the local level. This ability to construct a classifier for a particular
dataset is particularly important for researchers who work in smaller laboratories, deal
with a variety of organisms and/or tissues, employ a variety of protein extraction
protocols, and/or who use a centralized facility for proteomics where they have little
control over instrumental and analytical protocols.
We describe a method for constructing a classifier for a proteomics data set that
can predict peptide observability for a particular set of experimental conditions. We
demonstrate that the classifiers constructed using this method provide critical information
for assessing the validity of protein identifications and valuable evidence to support
competing hypotheses about the presence or absence of ―missing‖ proteins in a pathway
of interest.
The set of tryptic peptides that are observed under experimental conditions can be
divided into two classes – proteotrypic and flyable. Proteotrypic peptides are those
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experimentally observable peptides that can be used to uniquely identify a protein, while
flyable peptides are all peptides that are experimentally observable but may not be
proteotrypic [11]. Proteotypic peptides are a subset of flyable peptides and flyable
peptides are a subset of all possible tryptic peptides. The spectra generated by mass
spectrometry analysis of a complex peptide mixture are matched against theoretical
spectra generated from an in silico trypsin-digested protein database. The resulting set of
peptide identifications is then used for protein identification. Detection of at least one
proteotypic peptide is required for protein identification.
There is, however, disagreement among researchers about the number of peptide
matches and the peptide coverage of the protein that are required for a protein
identification to be considered valid. Protein identifications based on a single proteotypic
peptide (sometimes called ―one hit wonders‖) are often viewed with skepticism. Some
researchers contend that a protein identification needs at least two proteotypic peptides to
be valid, while others contend that a single high quality peptide can be used for
identification purposes [6]. Furthermore, some proteins produce only one proteotypic
peptide. In addition to the number of peptides identified, the degree of coverage of the
protein by peptides may also be used as a measure to assess the validity of the
identification—this is typically provided in terms of the percentage of amino acids in the
protein ―covered‖ by identified peptides. However, an additional and more meaningful
statistic is the percentage of potentially detectable peptides that are observed. This
information has the potential to increase (or decrease) the credibility of some single
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proteotypic peptides for identification and can prevent loss of important data [6] or the
inclusion of erroneous identifications.
Two other research groups have described methods for the prediction of peptide
detection using mass spectrometry, but their methods are distinct from ours. Mallick et
al. [7] have compiled a large training set from multiple yeast proteomics experiments
and built Gaussian mixture discriminant function predictors for a number of different
proteomics platforms. Their goal is to characterize the general properties of peptides that
can be detected using different proteomics technologies, to determine the coverage of the
predicted proteome that is detectable using different technologies, and they also argue
that their method can be used to improve protein quantification. Lu et al. [10] describe a
classifier for predicting peptide observability that is a component of a method for
absolute protein quantification and that adjusts scores for protein abundance based on the
predicted detectability of in silico generated tryptic peptides.

Cell Penetrating Peptides
Cell penetrating peptides (CPPs), also referred to as ―Trojan‖ peptides, protein
transduction domains, or membrane translocation sequences, are typically hydrophobic
linear arrangements of 8-24 amino acids able to cross the lipid bi-layer membrane that
serves as the cell’s outer barrier and gain access to the interior of the cell and its
components [12]. Penetratin, an Antennapedia derived peptide, and the HIV derived Tat
peptide were some of the first commonly studied CPPs, and along with transportan
peptides (derived from galanin receptor ligand proteins), make up three major families of
CPPs. The remainder of CPPs are classified in a fourth, miscellaneous family [12].
7

Cell penetrating peptides capable of transporting other active molecules inside the
cell have the potential to serve as drug delivery peptides. Although there is some
controversy regarding CPPs as drug delivery systems because of their lack of specificity
for cell type, the general consensus among researchers is that both general CPPs and cellspecific CPPs will be developed into effective drug delivery systems in the future [13,
14]. A classification system that can determine whether or not a peptide can serve as a
CPP can enable researchers to quickly screen candidate molecules for their potential
viability for use in a customizable drug delivery regime.
Much of the previous work in the prediction of CPPs has involved the use of a set
of composite features assembled from primary biochemical properties through the use of
principal component analysis [15-17]. These composite features, or z-scores, consist of a
numerical value and an associated range. To predict cell-penetrating capability of a
candidate peptide, the z-scores are computed for the peptide, and, if the z-scores fall
within the range of known CPP z-scores, the peptide is classified as cell-penetrating [16,
17]. While this method has a high accuracy (>95% correct prediction of novel CPPs) for
generating novel CPPs [16], it performs rather poorly (68% correct prediction) when
trying to distinguish known non-penetrating peptides that are closely related to known
CPPs [17] and yields little information about exactly which biochemical properties
contribute to the difference between these two classes. More recent work examines the
use of quantitative structure-activity relationship (QSAR) derived features to predict
penetration potential. The training process iteratively removes sequences that are
difficult to classify and thus the classification accuracies reported are biased [18].
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Further research into this topic is necessary to allow potential drug delivery peptides to be
rapidly screened for usefulness.
Using the basic biochemical properties of peptides as features instead of
composite z-scores can potentially provide more insight into the differences between the
class of CPPs and non-penetrating peptides when coupled with the use of a machine
learning classifier such as a support vector machine. Additionally, once trained, these
machine learning classifiers can then be used for rapid screening of candidate CPPs prior
to their synthesis.

Proteogenomic Mapping
Structural genome annotation is the process of identifying all of the structural
elements that comprise an organism’s sequenced genome. These structural elements can
include regions that code for proteins, both coding and non-coding RNAs, regulatory
regions, and DNA binding motifs. Traditionally, this has been accomplished through the
use of expressed sequence tags (ESTs) and cDNA libraries, transcribed RNA that is
reverse translated into DNA sequences. These ESTs and cDNAs generally represent
approximately 500-800 base pair mRNA sequences that are sequenced as they are, or
translated back into cDNA and then sequenced [19, 20]. These EST and cDNA libraries
are then aligned with the sequenced genome to identify regions representing exons and
whole genes that are actively transcribed [19, 20].
These library based-methods are typically complemented by the use of
computational gene finders. The computational gene finders use the EST and cDNA
libraries to identify patterns within the genome indicative of coding regions. This is
9

known as homology based computational annotation [19, 20]. Some programs can also
perform de novo based genome annotation where they detect signal information within
the genome and use these signals to predict coding regions [19]. Computational gene
prediction tools are known to produce a number of errors and significant resources are
dedicated to identifying and correcting these errors in genome annotation projects [19,
21]. It has been estimated that the exact genomic structure is only correctly identified by
computational gene finders 50-60% of the time within the human genome, the most well
sequenced and annotated genome [21]. Both homology-based methods and de novo
methods are effective for identifying new genetic sequences similar to known genes or
with known signals. However, these methods are ineffective for identifying new genes
with limited sequence similarity or signal information [19]. The use of high throughput
proteomics, in conjunction with the genome sequence, has the potential to provide
additional evidence for new genes or corrections to the boundaries of known genes.
The use of high throughput shotgun proteomics data derived from mass
spectrometry experiments is increasingly being used as a complementary method for
structural genome annotation [22]. This use of proteomics data to aid in genome
annotation began around 2001[23] for several prokaryotic projects, and was popularized
in 2004 by Jaffe et al., who coined the term proteogenomic mapping [1]. Proteomic
evidence, identified as expressed Protein Sequence Tags (ePSTs), provides proof that a
given gene is expressed, and when back translated and aligned with the sequenced
genome, provide structural annotation information for a genome’s functional elements
[22, 24]. This can include “confirmation of translation, reading-frame determination,
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identification of gene and exon boundaries, evidence for post translational processing,
identification of splice-forms including alternative splicing, and also, the prediction of
completely novel genes” [22]. Since the development of proteogenomic mapping, it has
been utilized in a number of both prokaryotic [1, 23, 25-31] and eukaryotic [9, 32-42]
genome annotation projects, and is increasingly becoming a part of standard annotation
pipelines utilizing multiple sources of evidence (sequenced nucleic acids, computational
gene prediction, and proteomics data) [20].

Summary
This dissertation uses proteomics data combined with machine learning tools to
contribute to the prediction of peptide properties and to improve the structural annotation
of the chicken genome. The dissertation demonstrates the use of proteomics data and
machine learning to solve three different bioinformatics problems. The remainder of this
dissertation reviews the relevant literature of the three proteomics problems, describes
and discusses the research performed, and presents the results of that research.
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CHAPTER II
PREDICTION OF PEPTIDES OBSERVABLE BY MASS SPECTROMETRY
APPLIED AT THE EXPERIMENTAL SET LEVEL

Abstract

Background
When proteins are subjected to proteolytic digestion and analyzed by mass
spectrometry using a method such as 2D LC MS/MS, only a portion of the proteotypic
peptides associated with each protein will be observed. A number of factors can
contribute to the inability to detect some peptides including protein extraction methods,
choice of proteolytic enzymes, properties of the peptides, experimental and
instrumentation conditions, non-covalent interactions by the peptides in the gas phase,
and changes to database search algorithms. The ability to predict which peptides can and
cannot potentially be observed for a particular experimental dataset has several important
applications in proteomics research including calculation of peptide coverage in terms of
potentially detectable peptides, systems biology analysis of data sets, and protein
quantification.
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Results
We have developed a methodology for constructing artificial neural networks that
can be used to predict which peptides are potentially observable for a given set of
experimental, instrumental, and analytical conditions for 2D LC MS/MS (a.k.a
Multidimensional Protein Identification Technology [MudPIT]) datasets. Neural network
classifiers constructed using this procedure for two MudPIT datasets exhibit 10-fold cross
validation accuracy of about 80%. We show that a classifier constructed for one dataset
has poor predictive performance with the other dataset, thus demonstrating the need for
dataset specific classifiers. Classification results with each dataset are used to compute
informative percent amino acid coverage statistics for each protein in terms of the
predicted detectable peptides in addition to the percent coverage of the complete
sequence. We also demonstrate the utility of predicted peptide observability for systems
analysis to help determine if proteins that were expected but not observed generate
sufficient peptides for detection.

Conclusions
Classifiers that accurately predict the likelihood of detecting proteotypic peptides
by mass spectrometry provide proteomics researchers with powerful new approaches for
data analysis. We demonstrate that the procedure we have developed for building a
classifier based on an individual experimental data set results in classifiers with accuracy
comparable to those reported in the literature based on large training sets collected from
multiple experiments. Our approach allows the researcher to construct a classifier that is
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specific for the experimental, instrument, and analytical conditions of a single experiment
and amenable to local, condition-specific, implementation. The resulting classifiers have
application in a number of areas such as determination of peptide coverage for protein
identification, pathway analysis, and protein quantification.

Background
In high-throughput non-electrophoretic proteomics complex mixtures of proteins
are subjected to proteolytic digestion with an enzyme such as trypsin before the
fragments are separated by liquid chromatography (LC) and analyzed by tandem mass
spectrometry. However, for a particular protein, only a portion of the peptides are
actually observed experimentally and the set of peptides that are observed from a single
protein can vary substantially from one experiment to another. A number of factors
contribute to the inability to detect some peptides and to variations in the peptides that are
detected from one experiment to another. These include incomplete proteolytic
digestion, small size, poor binding or elution from the type of LC column used, the
limited mass range that can be detected by the mass spectrometer, bias toward detecting
peptides with an intense MS signal in mixtures, the phenomenon of ―ion suppression‖,
the charge prior to ionization, and non-covalent interactions between peptides in the gas
phase while in the mass spectrometer [1]. In addition, there are substantial differences in
the peptides observed due to variations in the protein extraction and or solublization
methods, tissue types, prefractionation, LC separation conditions, and differences
between gradients even when the same LC separation conditions are used. Furthermore,
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different databases, different search software and even different versions of the same
software also influence which peptides that are detected.
We refer to peptides that can be detected as ―flyable‖. The fact that most proteins
in a complex mixture are represented by only a small number of proteolytic peptides
presents several difficulties for proteomics researchers [2]. These problems include
assessment of the level of confidence in protein identifications [3], determining the
peptide coverage of proteins [4], determining if ―missing‖ proteins are potentially
observable [5, 6], and using peptide observability as an adjustment factor for protein
quantification based on observed peptides [4, 7]. Recently reported methods for
predicting peptide observability have been based on large training datasets from multiple
experiments dealing with a single organism [4, 7]. However, because the observability of
peptides depends not only on the properties of the peptides themselves but also on
specific experimental, instrumental, and analytical procedures, we contend that it is
necessary to provide a method for predicting peptide observability for a specific
experimental set at the local level. This ability to construct a classifier for a particular
dataset is particularly important for researchers who work in smaller laboratories, deal
with a variety of organisms and/or tissues, employ a variety of protein extraction
protocols, and/or who use a centralized facility for proteomics where they have little
control over instrumental and analytical protocols.
Here we describe a method for constructing a classifier for a proteomics data set
that can predict peptide observability for a particular set of experimental conditions. We
demonstrate that the classifiers constructed using this method provide critical information
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for assessing the validity of protein identifications and valuable evidence to support
competing hypotheses about the presence or absence of ―missing‖ proteins in a pathway
of interest.
The set of tryptic peptides that are observed under experimental conditions can be
divided into two classes – proteotrypic and flyable. Proteotrypic peptides are those
experimentally observable peptides that can be used to uniquely identify a protein, while
flyable peptides are all peptides that are experimentally observable but may not be
proteotrypic [8]. Proteotypic peptides are a subset of flyable peptides and flyable
peptides are a subset of all possible tryptic peptides. The spectra generated by mass
spectrometry analysis of a complex peptide mixture are matched against theoretical
spectra generated from an in silico trypsin-digested protein database. The resulting set of
peptide identifications is then used for protein identification. By definition, detection of at
least one proteotypic peptide is required for protein identification.
There is, however, disagreement among researchers about the number of peptide
matches and the peptide coverage of the protein that are required for an identification to
be considered valid. Protein identifications based on a single proteotypic peptide
(sometimes called ―one hit wonders‖) are often viewed with skepticism. Some
researchers contend that a protein identification needs at least two proteotypic peptides to
be valid, while others contend that a single high quality peptide can be used for
identification purposes [3]. Furthermore, some proteins produce only one proteotypic
peptide. In addition to the number of peptides identified, the degree of coverage of the
protein by peptides may also be used as a measure to assess the validity of the
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identification—this is typically provided in terms of the percentage of amino acids in the
protein ―covered‖ by identified peptides. However, an additional and more meaningful
statistic is the percentage of potentially detectable peptides that are observed. This
information has the potential to increase (or decrease) the credibility of some single
proteotypic peptides for identification and can prevent loss of important data [3] or the
inclusion of erroneous identifications.
Researchers using proteomics are interested in not only cataloging proteins
present, but also in studying the location and differential expression of the proteins
involved in biochemical pathways [2]. Often, one or more proteins referenced to
participate in a canonical pathway are not observed in a proteomics dataset, but most
other proteins in the pathway are present [5, 6]. Conversely, a protein that has never been
identified in that pathway may be identified by a single proteotypic peptide. In the first
case, it is important to know whether these missing proteins generate a sufficient number
of potentially observable proteotypic peptides to support identification under the specific
experimental conditions or whether the protein truly appears to be absent. In the second
case, it is important to determine if a protein may reasonably be expected to be identified
by only one peptide under the experimental conditions—an identification of a protein
with a single peptide where the protein is predicted to produce many observable
proteotypic peptides should be viewed with suspicion.
Two recently published papers describe methods for the prediction of peptide
detection using mass spectrometry, but their methods are distinct from ours. Mallick et
al. [4] have compiled a large training set from multiple yeast proteomics experiments
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and built Gaussian mixture discriminant function predictors for a number of different
proteomics platforms. Their goal is to characterize the general properties of peptides that
can be detected using different proteomics technologies, to determine the coverage of the
predicted proteome that is detectable using different technologies, and they also argue
that their method can be used to improve protein quantification. Lu et al. [7] describe a
classifier for predicting peptide observability that is a component of a method for
absolute protein quantification and that adjusts scores for protein abundance based on the
predicted detectability of in silico generated tryptic peptides. In contrast, our procedure
is specifically developed for generating a classifier for a single data set to predict flyable
peptides for a particular set of experimental conditions (biological sample, protein
extraction protocol, mass spectrometric instrumentation, HPLC column type, database
search algorithm and settings, etc.) and to be applied locally. We demonstrate that the
resulting classification provides valuable information with regard to peptide coverage of
a protein and can assist the proteomics researcher in a systems analysis of the dataset.

Results and Discussion
We have developed a procedure for building a classifier to predict peptide
flyability from a proteomics dataset. The output of the protein identification algorithms
for a proteomics dataset includes the proteins that were identified and the peptides that
were used for each protein identification. As Figure 2.1 illustrates, the classifier
construction process includes selection of a set of observed and unobserved peptides for
the training set, extraction of features to represent the peptides in the training set,
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normalization of the feature values, feature subset selection, and training and testing of
the classifier.

Training Set Compilation Strategy
The first step in the process is selection of a set of peptides for the training data set.
The naïve approach is to use all observed peptides for the positive examples and all nonobserved in silico generated peptides from identified proteins for the negative examples.
However, this approach ignores several complications that arise when processing
proteomics datasets. First, some of the ―observed‖ peptides will be false positive
identifications. The probability that a peptide is a false positive identification is greatly
reduced if it is one of multiple peptides used to identify a protein since the probability of
this occurring by chance is small [3]. Therefore, we limit the positive examples to the
peptides associated with proteins that were identified using multiple unique peptides.
Peptides chosen for negative examples are also limited to the set of proteins identified by
multiple peptides. However, selection of negative examples is also complicated by the
fact that the number peptides observed for a protein is directly related to protein
abundance in the sample. Isotope-free quantification methods for proteomics datasets
make use of the relationship between the number of peptides observed and protein
concentration [9-12]. To avoid the problem of labeling peptides that were not observed
as negative examples because they are associated with low abundance proteins, we have
chosen to compile the negative examples from the proteins that were identified with the
largest number of peptides. Although this introduces a bias for peptides from abundant
and large proteins, this strategy insures, to the extent possible, that the peptides used for
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negative examples were present in sufficient quantity to be potentially observable. We
have developed the following procedure for selection of the training set to ensure that the
peptides selected for the class of observable peptides are high confidence identifications
and that the peptides selected for the negative examples are truly ―unobservable‖ under
the specific experimental conditions.
1. Rank the protein identifications by the number of peptides used in the identification
and include only identifications based at least two distinct peptides.
2. Retrieve the amino acid sequence for each of the proteins in step 1, perform in silico
trypsin (or appropriate enzyme) digestion of the proteins, and compile a list of all
predicted tryptic peptides of length greater than 6 amino acids (because this number
gives a probability of the sequence identifying another sequence at random of 1 in 196
and which is reasonable for a eukaryote genome of around 4 billion base-pairs such as
human).
3. If a peptide is present in the experimental data, it is assigned a value of 1 and if it is
not observed in the experimental data it is given a value of 0. There will be many
more with a value of 0 than with 1.
4. The peptides labeled with a 1 in the previous step are used as the positive examples in
the training set. Suppose the size of this set is n. In order assure that peptides used as
negative examples were present in sufficient quantity for detection and to also help
produce a balanced training set, we select the first n ―unobserved‖ peptides from the
proteins ranked by the number of peptides used for identification.

Feature Generation and Classifier Construction
Our approach for generating features to represent each peptide in the training set
uses both the features listed in Table 2.1 (called Feature Set 1) and features constructed
using properties from the AAIndex [13]. The first set of features (see Table 2.1)
includes basic properties of the peptide (e.g. mass and size) and features related to the
amino acid composition of the peptide. The AA Index is a compilation in a set of tables
of 544 different indices used to characterize amino acids. It includes indices for wide
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variety of characteristics of amino acids including hydrophobicity, participation in certain
types of structures, etc. A feature value was generated for each peptide for each index
representing the sum of the index values for all amino acids in the peptide. Combination
of Feature Set 1 and the AAindex features results in a total of 596 features for each
peptide. Although this set includes a large number of redundant features, we have shown
that using both sets as input for the feature selection process yields improved classifier
performance over use of each feature set alone. For example, with the avian bursal
dataset described below, the 10-fold classification accuracy of neural networks built with
the AAIndex features only is 72%, with Feature Set 1 only is 71%, and with both feature
sets is 81%. Because the values of the features cover a wide range of numeric values,
NV normalization is used to make the numeric range of all features 0-1. Feature subset
selection is then performed to find the set of feature most relevant to the task of
predicting flyability and to remove redundant and non-informative features. We use a
feature selection method that performs a greedy search through feature space to identify
features based on the level of consistency with class values when the training data is
compared to the entire set of attributes [14]. The reduced set of features is used to train
the classifier. A 3-layer neural network classifier is constructed with an input unit for
each of the selected features, (i+1)/2 hidden units where i is the number of input units,
and a single output unit. The neural network is trained using the training set constructed
with the strategy described above and tested using 10-fold cross validation. Multilayer
neural networks provide a robust method for learning a functional mapping from numeric

25

attribute values to a class value—in this case a mapping from numeric features describing
the peptide to the classes ―observable‖ and ―unobservable.‖
In order to demonstrate the utility of our approach, we have used the methodology
described above to build classifiers for two different published MudPIT data sets: 1) an
avian bursa of Fabricius data set consisting of 5198 proteins [6], and 2) a Hodgkin’s
lymphoma model data set consisting of 3983 proteins [5]. The classifiers built using our
procedure had 10-fold cross validation classification accuracies of 81% and 72%
respectively. Table 2.2 lists the features selected that best distinguish observed peptides
from unobservable peptides for both datasets. Table 2.3 reports the accuracy and
confusion matrices for the neural networks for both data sets based on 10-fold cross
validation.
The features selected tend to be related to structural properties of the peptides.
For example, consider the features selected for the avian bursa classifier. Prolines tend
to break alpha helices and prolines located adjacent to lysine or arginine also interfere
with trypsin digestion. Amino acids with small side chains such as glycine and alanine
increase the flexibility of the peptide. The charge, polarity, hydrophobicity, and the
behavior of the peptide in solvent also influence flyability.
Our classifiers achieved classification accuracies comparable to the rates reported
by Mallick et al. [4] and Lu et al. [7] for much simpler yeast systems. The accuracy
statistics reported by Mallick et al. are difficult to compare to ours because they report
specificity in terms of (1 - positive predictive ratio) where the positive predictive ratio is
defined as (true positives/(true positives + false positives)) rather than the more
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traditional true positive ratio (true positives/(true positives + false negatives). Lu et al.
report a 69% true positive rate for observed and a 90% true positive rate for nonobserved. Note that it is possible to achieve an 82% true positive rate for the nonobserved class for their classifier by guessing non-observed in every case. In addition,
they include very small peptides (3 -5 aa) in their analysis and we exclude peptides of this
length from our study because of the high probability of random matches to multiple
proteins and their lack of power as unique identifiers.
In order to evaluate the importance of building classifiers that are specific for a
particular dataset, we tested each of the classifiers above with the data used for training
the other classifier (i.e. avian bursal classifier with Hodgkin’s lymphoma model data set
as test set and vice versa). The results (Table 2.4) demonstrate that there is a substantial
loss of classifier accuracy when using a classifier trained with one data set to predict
peptide observability with the other data set. In both cases, the true positive rate
(prediction of observability) decreased dramatically (almost to the level that would be
achieved by random guessing). These results are consistent with those reported by
Mallick et al. [4] when a classifier trained with yeast data was used to predict
observability with human data. These results clearly demonstrate the need for classifiers
to be trained for each experimental set.
We use the two classifiers described above for the avian bursa dataset and the
Hodgkin’s lymphoma model dataset to demonstrate the utility of the classifiers for
calculating an informative peptide coverage statistic for proteins and for analysis of
system’s biology datasets. In Table 2.4 the sections in white show, for a subset of
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proteins that were observed in the data, the total number of tryptic peptides generated by
in silico tryptic digestion, the number observed, the number of peptides predicted to be
detectable by each classifier, and the amino acid coverage both in terms of the total
number of tryptic peptides and in terms of those predicted to be observable. As
expected, in most cases the amino acid coverage for peptides predicted to be detectable is
higher, sometimes substantially higher, than the total amino acid coverage. In general,
this approach allows the researcher to determine how many peptides might reasonably be
expected to be detected.
We have also used the bursal neural network and the Hodgkin’s lymphoma model
neural network to determine if proteins that are ―missing‖ from a pathway of interest are
likely to be potentially observable. The results are given in Table 2.5. As McCarthy et
al. [6] reported, most components of the programmed cell death pathway with known
orthologs in chicken were observed in the avian bursa data set with the exception of the
protein DR3. The peptides produced by in silico tryptic digestion of DR3 (GI
118106991) were used as input to our neural network for this data set. As shown in
Table 2.5 (yellow section), none of the peptides for this protein were predicted to be
observable. In contrast, for proteins that were observed, the average number of
observable peptides was 5. For the Hodgkin’s lymphoma model dataset, there were five
proteins that we expected to observe because we have observed them using other
methods in other experiments [15, 16] but we did not see them in this experiment (shown
in yellow in Table 2.4). The results in Table 2.5 show that none of the tryptic peptides
for these proteins is predicted to be observable under the given experimental conditions
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while a set of proteins of similar size that were observed were predicted to be observable.
Although these results cannot be used to demonstrate conclusively that a protein does or
does not exist in a data set, they can be used as one piece of evidence to confirm or refute
a hypothesis about the presence of a protein under certain conditions and to plan further
wet lab experiments.

Conclusions
We present a procedure for constructing a classifier to predict which tryptic
peptides in a protein are likely to be detectable by mass spectrometry for a specific set of
experimental and instrumental conditions. We demonstrate that it is possible to construct
a classifier with accuracy comparable to those previously reported based on the
accumulation of large training sets from multiple experiments. We also show that a
classifier constructed based on one dataset does not perform at an acceptable level when
predicting observability for another dataset and thus it is necessary to construct
classifiers that are specific for one set of experimental conditions. The resulting classifier
provides researchers with a tool that can provide information about peptide coverage of
proteins in terms of which proteins are likely to be detectable. It can also be used as one
line of evidence in a systems analysis to evaluate alternative hypotheses concerning
proteins that were not observed but that were expected. If the ―missing‖ protein
generates many predicted detectable peptides but none were observed, then this provides
additional probabilistic evidence of absence of the protein—a very difficult hypothesis to
demonstrate conclusively. The classifier allows researchers to distinguish between
proteins that are not likely to be detected with the methodology versus proteins that were
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not expressed in the biological system. Only by making this distinction is it possible to
accurately interpret proteomics results and improve biological modeling.

Methods

Biological Samples
Methods used to collect the biological samples, analyze the samples using mass
spectrometry, and identify proteins are described in detail in[5] and [6]. All samples
were analyzed by MudPIT using an LCQ Deca XP Plus IT mass spectrometer and
database search was conducted using TurboSEQUEST (Bioworks Browser;
ThermoElectron ).

Software
Custom Perl scripts were written to extract the accessions of proteins and lists of
peptides from Sequest output files, to query NCBI and download the protein sequences,
to trypsin digest the proteins, to determine which peptides had been observed in the
dataset, to select the positive and negative peptides for the data sets, and to compute the
feature vectors for each peptide. The software implements the rules for trypsin digestion
described for the ExPASy PeptideCutter tool [17]. WEKA Explorer Version 3.4.10, a
software package containing a collection of machine learning algorithms for data mining
available at http://www.cs.waikato.ac.nz/ml/weka/ [14] was used for feature selection,
and building and testing the classifier.

The software that generates a training set from a

Sequest output file and a detailed readme describing how to generate classifiers for a
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specific dataset using Weka is available for download in the Tools section of AgBase
(www.agbase.msstate.edu).
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TABLE 2.1
A LIST OF INITIAL FEATURES USED FOR CLASSIFIER CONSTRUCTION IN
ADDITION TO AAINDEX FEATURES.
Feature Subset 1
Length of peptide
Net charge of peptide
Positive charge
Negative charge
Isoelectric point
Molecular weight
Hydropathicity
Count of each amino acid (20 features)
Percent composition of each amino acid (20
features)
Percent polar amino acids
Percent positive amino acids
Percent negative amino acids
Percent hydrophobic amino acids
NOTE: A feature selection procedure is used to reduce dimensionality prior to classifier
construction.
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TABLE 2.2
DESCRIPTION OF FEATURES SELECTED FOR THE CLASSIFIERS BUILT FOR
THE TWO DATASETS.
Avian Bursa Dataset
Number of prolines
Percent glycine
Percent alanine
Percent leucine
Percent polar amino acids
Percent hydrophobic amino acids
Percent positive amino acids
Percent negative
Size (Dawson, 1972)
Optimized transfer energy parameter (Oobatake et al., 1985)
Weights for beta-sheet at the window position of 5 (Qian-Sejnowski, 1988)
Transfer free energy from oct to wat (Radzicka-Wolfenden, 1988)
Information measure for C-terminal turn (Robson-Suzuki, 1976)
Amphiphilicity index (Mitaku et al., 2002)
Hodgkin’s Lymphoma Model Dataset
Number of cysteine
Signal sequence helical potential (Argos et al., 1982)
Transfer free energy to surface (Bull-Breese, 1974)
Normalized relative frequency of alpha-helix (Isogai et al., 1980)
Normalized relative frequence of double bend (Isogai et al., 1980)
Distance between C-alpha and centroid of side chain (Levitt, 1976)
Retention coefficient in NAH2PO4 (Meek-Rossetti, 1981)
Interior composition of amino acids intracellular proteins (FukuchiNishikawa, 2001)
Linker propensity from 1-linker dataset (George-Heringa, 2003)
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TABLE 2.3
10-FOLD CROSS-VALIDATION ACCURACY BY CLASS FOR NEURAL
NETWORKS GENERATED FOR TWO DATASETS.

Class
Avian Bursal Dataset
Not observed
Observed

True
False
positive positive
ROC
rate
rate
Precision Recall Area
0.80
0.82

0.19
0.20

0.81
0.80

0.80
0.82

0.87
0.87

Hodgkin's Lymphoma Model Dataset
Not observed
0.66
Observed
0.78

0.22
0.34

0.75
0.70

0.66
0.78

0.80
0.80

TABLE 2.4
ACCURACY BY CLASS FOR NEURAL NETWORKS GENERATED USING ONE
DATASET AS THE TRAINING SET AND THE OTHER DATASET FOR TEST
DATA.
True
False
positive positive
ROC
Class
rate
rate
Precision Recall Area
Avian Bursal Dataset training set, Hodgkins Lymphoma test set
Not observed
0.71
0.46
0.61
0.71 0.70
Observed
0.54
0.29
0.66
0.54 0.70
Hodgkin's Lymphoma Model Dataset training set, Avian Bursa test set
Not observed
0.81
0.41
0.81
0.73
Observed
0.59
0.19
0.59
0.66
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0.73
0.73

TABLE 2.5
NUMBER OF TRYPTIC PEPTIDES PREDICTED TO BE OBSERVABLE FOR
SELECTED PROTEINS FROM THE TWO DATA SETS.

Num
Num
Protein
tryptic
tryptic
GI
peptides
peptides
Number
( >= 6 aa) observed
Avian bursa data set
5902793
20
2
119359
50
5
128413
16
2
2119012
7
2
17025728
16
2
122000
6
4
1762374
7
1
1172808
13
1
7512219
44
1
104697
9
2
118106991
12
0
Hodgkin’s lymphoma model data set
479367
34
1
729629
18
2
899264
13
1
63544
48
2
50750413
38
3
45433516
26
0
46048702
14
0
125745137
9
0
125745114
9
0
45433516
26
0

Percent
amino
Percent
acid
amino
Number
Percent
coverage
acid
predicted predicted of
coverage detectable detectable detectable
10
9
11
28
6
33
23
6
2
22
0

9
15
3
3
7
0
2
4
11
4
0

45
30
18
43
44
0
29
30
25
44
0

33
21
14
17
20
0
21
19
34
30
0

3
14
10
2
11
0
0
0
0
0

5
11
4
6
8
0
0
0
0
0

15
61
31
13
21
0
0
0
0
0

11
43
21
15
25
0
0
0
0
0

NOTE: 1) For the avian bursa dataset, 10 randomly selected observed proteins (in white)
and the DR3 protein that was expected but not observed (in yellow). 2) For the Hodgkin’s
lymphoma model dataset, 5 proteins that were observed in the pathway under
consideration and 5 (in yellow) that had been observed using other methods in previous
experiments but not observed in this dataset.
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CHAPTER III
PREDICTION OF CELL PENETRATING PEPTIDES BY SUPPORT VECTOR
MACHINES

Abstract
Cell penetrating peptides (CPPs) are those peptides that can transverse cell
membranes to enter cells. Once inside the cell, different CPPs can localize to different
cellular components and perform different roles. Some generate pore-forming complexes
resulting in the destruction of cells while others localize to various organelles. Use of
machine learning methods to predict potential new CPPs will enable more rapid
screening for applications such as drug delivery. We have investigated the influence of
the composition of training datasets on the ability to classify peptides as cell penetrating
using support vector machines (SVMs). We identified 111 known CPPs and 34 known
non-penetrating peptides from the literature and commercial vendors and used several
approaches to build training data sets for the classifiers. Features were calculated from
the datasets using a set of basic biochemical properties combined with features from the
literature determined to be relevant in the prediction of CPPs. Our results using different
training datasets confirm the importance of a balanced training set with approximately
equal number of positive and negative examples. The SVM based classifiers have greater
classification accuracy than previously reported methods for the prediction of CPPs, and
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because they use primary biochemical properties of the peptides as features, these
classifiers provide insight into the properties needed for cell-penetration. To confirm our
SVM classifications, a subset of peptides classified as either penetrating or nonpenetrating was selected for synthesis and experimental validation. Of the synthesized
peptides predicted to be CPPs, 100% of these peptides were shown to be penetrating.

Introduction
Cell penetrating peptides (CPPs), also referred to as "Trojan" peptides, protein
transduction domains, or membrane translocation sequences, are typically hydrophobic
linear arrangements of 8-24 amino acids able to cross the lipid bi-layer membrane that
serves as the cell’s outer barrier and gain access to the interior of the cell and its
components [1]. Penetratin, an Antennapedia derived peptide, and the HIV derived Tat
peptide were some of the first commonly studied CPPs, and along with transportan
peptides (derived from galanin receptor ligand proteins), make up three major families of
CPPs. The remainder of CPPs are classified in a fourth, miscellaneous family [1].
Initially, cellular uptake of CPPs was believed to be through endocytosis or
protein transporters, but some evidence suggested the mechanism may involve direct
transport through the lipid bi-layer of the cell, which takes into account the hydrophobic
properties of most of these peptides [2]. The current view is that CPP internalization is
accomplished predominantly by endocytosis [3]. Historically, both flow cytometry and
fluorescence microscopy have been used to study the uptake of CPPs into cells. Care
must be used with these methods to avoid artifacts because traditional methodologies for
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these techniques can incorrectly show a high concentration of CPPs localizing to the cell
nucleus or a higher than actual concentration of CPPs being taken into the cell [2].
Cell penetrating peptides capable of transporting other active molecules inside the
cell have the potential to serve as drug delivery peptides. Drug delivery peptides and
CPPs allow researchers to probe the mechanisms of peptide transport across a lipid bilayer membrane and may allow customizable drug therapies for differing types of cells.
Although there is some controversy regarding CPPs as drug delivery systems because of
their lack of specificity for cell type, the general consensus among researchers is that both
general CPPs and cell-specific CPPs will be developed into effective drug delivery
systems in the future [4, 5].
A classification system that can determine whether or not a unique peptide
sequence can serve as a CPP, and thus possibly be a potential drug delivery peptide, can
enable researchers to quickly screen candidate molecules for their potential viability for
use in a customizable drug delivery regime.
Much of the previous work in the prediction of CPPs has involved the use of a set
of composite features assembled from primary biochemical properties through the use of
principal component analysis [6-8]. These composite features, or z-scores, consist of a
numerical value and an associated range. To predict cell-penetrating capability of a
candidate peptide, the z-scores are computed for the peptide, and, if the z-scores fall
within the range of known CPP z-scores, the peptide is classified as cell-penetrating [7,
8]. While this method has a high accuracy (>95% correct prediction of novel CPPs) for
generating novel CPPs [7], it performs rather poorly (68% correct prediction) when
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trying to distinguish known non-penetrating peptides that are closely related to known
CPPs [8] and yields little information about exactly which biochemical properties
contribute to the difference between these two classes. More recent work examines the
use of quantitative structure-activity relationship (QSAR) derived features to predict
penetration potential. The training process iteratively removes sequences that are
difficult to classify and thus the classification accuracies reported are biased [9]. Further
research into this topic is necessary to allow potential drug delivery peptides to be rapidly
screened for usefulness.
Using the basic biochemical properties of peptides as features instead of the
widely used composite z-scores can potentially provide more insight into the differences
between the class of CPPs and non-penetrating peptides when coupled with the use of a
machine learning classifier such as a support vector machine. Additionally, once trained,
these machine learning classifiers can then be used for rapid screening of candidate CPPs
prior to their synthesis. This study examines the available information on known CPPs
and their non-penetrating analogs in order to compile datasets used for training and
testing of support vector machine classifiers using primary features derived from
biochemical properties of each peptide and evaluates the accuracy of these classifiers.
An experimental validation study was performed to determine the effectiveness of these
classifiers using an avian tissue culture system.
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Results and Discussion
The goal of this study was to develop a machine learning approach for rapid
screening of potential CPPs. We use features representing primary biochemical
properties directly rather than using a transformation such as PCA that combines multiple
features into a single composite feature as reported by others [6-8]. In addition, we have
investigated the best approach for constructing training datasets when there is a large
disparity in the number of positive and negative examples. Previous research has shown
that unbalanced datasets are problematic when constructing classifiers [10]. We first
identified known CPPs and known non-penetrating peptides from the literature to serve
as positive and negative examples and calculated a number of primary biochemical
properties for each of these peptides. We then explored a number of different approaches
for addressing the problem of unbalanced datasets and evaluated classification accuracy
with the different approaches. A wrapper based feature selection method was utilized to
reduce the number of features needed for classification while providing insight into the
biochemical properties necessary to distinguish CPPs from non-CPPs. We have used
support vector machine classifiers because of their ability to linearly separate classes in a
high dimensional feature space. Classifier accuracy on our training sets was assessed
using 10-fold cross validation and then each classifier was tested again using the
unbalanced test set assembled from the literature. In order to experimentally validate
these results, a dataset of 250 peptides was created using a 0th order Markov model based
on the predicted chicken proteome [11], and these peptides were classified as either
penetrating or non-penetrating by our classifier. Subsets of both predicted penetrating
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and predicted non-penetrating peptides were selected from these classification results and
were synthesized.

Experimental validation of cell penetration capability was then

determined using fluorescence microscopy and the quantitative uptake of peptides shown
to be penetrating was performed.

Dataset Construction Approaches
Because of the sensitivity of classifiers to unbalanced classes [10], our first
challenge was to generate datasets for training and testing. A set of 111 known CPPs
were identified from the literature [7, 8, 12]. However, only 34 negative examples could
be found and many of these are analogs of known CPPs [7, 8]. Unbalanced datasets
present a number of different problems for machine learning methods [10]. When only a
comparatively small number of examples are available for one class, the machine
learning algorithm will not have sufficient information to learn a function to distinguish
the classes. Reporting of classification accuracy is also impacted by unbalanced datasets.
For example, if a dataset of 100 peptides contains 80 CPPs and 20 non-CPPs, a
classification accuracy of 80% can be obtained by classifying all peptides as positive.
Most previous work in CPP prediction has ignored this problem [8, 9].
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We designed an experiment to investigate the effect of unbalanced datasets on CPP
prediction and to find methods to address the problem to evaluate classifier accuracy with
precision. For the CPP prediction problem, there are many more positive examples than
negative examples available. Five different approaches were used to generate training
datasets for investigating this issue:

1. Unbalanced: Composed of 34 known negative examples and 111 known positive
examples.
2. Balanced with random peptides as negative examples. 111 random peptides were
generated using a 0th order Markov chain based on the chicken proteome and
combined with 111 known positive examples. All random peptides were assumed
to be non-penetrating. This approach is based on the assumption that the
probability of randomly generating a CPP sequence is very small.
3. Balanced with biological peptides as negative examples. All chicken peptides of
length 12-26 AA were downloaded from NCBI and a sample of 111 was drawn
without replacement. All were assumed to be non-penetrating. This approach
assumes that most biological peptides are non-CPP and the probability of drawing
a CPP from this set is extremely low.
4. Balanced by sampling known negatives. Random sampling with replacement from
the 34 known negatives was used to yield a set of 111 negative examples that was
combined with the 111 positive examples.
5. Balanced by sampling known positives. Random sampling with replacement from
the 111 known positive examples to yield a set of 34 positive examples that was
combined with the 34 known negative examples.

Classifier Performance
The performance of all classifiers on the training data sets is based on 10-fold
cross validation. The confusion matrices for classifiers trained using datasets based on
approaches 1-4 are shown in Table 3.1 and the classifier statistics are shown in Table 3.2.
The classifier trained on the unbalanced dataset (111 positive examples and 34 negative
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examples) has a classification accuracy of only 75.86% compared to the naïve approach
of classifying all examples as positive which would result in a classification accuracy of
76.55%. The results for this dataset in Table 3.1 show that the resulting classifier
predicts almost all examples to be positive. This highlights the problems encountered
when using an unbalanced dataset. The classifier cannot distinguish positive and
negative examples because the dataset contains so many more positive examples than
negative examples and because many of the negative examples are analogs of the
positives.
The classifiers trained using both the dataset balanced with random peptides for
negatives (approach 2) and with biological peptides for negatives (approach 3) had
classification accuracies of 95.95% and 94.14% respectively, indicating that both
classifiers exhibit a high degree of accuracy in discriminating between known cellpenetrating peptides and randomly generated or biological peptides assumed to be
negative. The confusion tables for these classifiers on the training data sets (Table 3.1)
show that most of the mistakes are false negatives (CPPs incorrectly classified as nonCPPs). The weakness of these training approaches is that some of the assumed negative
examples may in fact be cell penetrating and known non-cell penetrating analogs of CPPs
were not used as negative examples. When we used these trained classifiers to evaluate
the known non-penetrating cell penetrating analog peptides (our unbalanced test data set)
these classifiers obtained accuracies of 80.69% and 79.31% respectively. For both
classifiers, approximately one third of the known non-penetrating peptides are classified
as cell-penetrating. Most of the mistakes made by these two classifiers on the test data
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seem to be false positives, that is classifying a peptide with no cell penetrating potential
as a CPP, and this classification of known non-penetrating cell penetrating analogs
demonstrates that while these classifiers are very accurate distinguishing the features
strongly predictive of cell penetrating potential from the vast majority of non-penetrating
peptides, the features used for classification do not serve to distinguish between peptides
more similar to CPPs that do not penetrate and those peptides that can act as CPPs.
The classifier trained on the data set constructed using approach 4 (random
sampling with replacement from the known negative examples) has a classification
accuracy of 88.74% on the training data set when evaluated with 10-fold cross validation.
When compared to the classification accuracy of the dataset generated using the
unbalanced dataset, these results show that it is possible to classify a set of CPPs and a set
of known non-penetrating peptides using our SVM based method when care is used to
construct balanced datasets. Table 3.2 shows that 60% of the errors are false positives
(non-CPPs incorrectly classified as CPPs). When we evaluated the unbalanced test set on
this classifier, an accuracy of 91.72% was obtained. The classifiers trained on the smaller
datasets using approach 5 have an average classification accuracy of 78.82% using 10fold cross validation.
Approach 2 using randomly selected biological peptides as the negative examples
gives the best 10-fold cross validation accuracy while approach 4 with random selection
from the negative examples gives the best accuracy for the unbalanced training set. This
suggests use of a two step process for screening. In the first step, a classifier trained with
random biological peptides as the negative examples would be used for preliminary bulk
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screening. As a second step, peptides predicted to be CPP in step 1 would be screened by
a classifier trained using approach 4 that is more accurate in distinguishing nonpenetrating analogs from CPPs. Approach 4 also provides more insight into the rational
design of novel CPP analogs as the negative examples used in this approach are generally
constructed by the modification of a known CPP sequence.
In Hällbrink et al. (2005), the authors describe a method of CPP prediction based
on scoring a candidate peptide according to z-score descriptors, features compiled
through PCA, and report an 84.05% accuracy in the prediction of 53 CPPs and 16 nonfunctional CPP analogs [7]. A follow-up to this study, utilizing both more known CPPs
(65) and more non-functional CPP analogs (20), reports a 68% prediction efficiency
using the same z-score descriptor based prediction method [8]. More recently, these zscore descriptors were utilized alongside quantitative structure-activity relationship
features in an artificial neural network (ANN) to predict cell penetrating potential for a
set of 101 peptides (77 CPPs, 24 non-penetrating CPP analogs) and report a classification
accuracy of 83% for the general ANN model constructed [9]. However, it should be
noted that the data set utilized is composed of unbalanced classes, and an accuracy of
76.24% can be achieved by classifying every peptide encountered as a CPP. A
comparison of these previously published prediction methods and our approach is
presented in Table 3.3. The models constructed using our approaches and their high
classification accuracies indicate that using the primary biochemical properties of a
peptide as features instead of synthesized feature values compiled using PCA allows for a
more informative analysis of which properties determine whether a given peptide is cell-
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penetrating. Our approach also allows predictive models constructed on training sets to
be used for more rapid and elucidative screening of cell-penetrating potential than
previous predictive methods based on verifying whether a given peptide falls within some
average range of composite features.
For each classifier constructed, feature selection was conducted using a scatter
search approach through feature space [13] where the “wrapped” classifier was the same
type of SVM used for classifier construction. The classifier is a sequential minimal
optimization SVM [14] using the Pearson Universal Kernel [15]. Table 3.4 lists the
features selected for datasets 1-4 above. Because the number of training/testing samples
for dataset 5 was so small, we generated ten different datasets using this approach. The
features selected from these ten datasets are listed in Table 3.5. The features selected for
the datasets constructed using approaches 1-5 contain a number of properties previously
shown to aid in the prediction of CPPs. These include net charge, positive charge,
negative charge, the net donated hydrogen bonds, and the water-octanol partition
coefficient. The low number of features selected for the datasets constructed using
approach 5 indicates over-fitting of these small datasets by the classification algorithm.
Therefore our detailed examination of features selected focused on datasets generated
using approaches 1-4.

The primary amino acid composition features, the number of a

given amino acid and the percent a given amino acid contributes to the whole peptide
sequence, indicates no predictive function arising from the non-polar amino acids leucine
and isoleucine, the polar amino acid glutamine, and the negatively charged amino acid
glutamate. At least one of the amino acid composition features was selected for the
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remaining amino acids, with the most notable of these being the positively charged amino
acids lysine, arginine, and histidine, and the negatively charged amino acid aspartate. In
addition, the group of aromatic amino acids were selected to a notable degree, and the
presence of some aromatic amino acids in the peptide sequence has been previously
reported to be required for cell-penetrating potential [16].

Validation study
To experimentally validate our feature selection methodology and classifiers, 250
random peptides were generated using a 0th order Markov model based on the chicken
predicted proteome and were classified as penetrating or non-penetrating using the
classifier trained on the dataset constructed using random peptides as negative examples.
From these classifications, four peptides predicted to be cell-penetrating and two peptides
predicted to be non-penetrating were selected for synthesis and FITC-labeling along with
three known cell penetrating peptides used for positive controls, three peptides consisting
respectively of only polar amino acids, only non-polar amino acids, and only of mixed
polar and non-polar amino acids to serve as negative controls. In addition, a known nonpenetrating peptide (TP13, a transportan analog [16]) was selected for synthesis to serve
as a minor validation for our set of known non-penetrating peptides.

Cellular Internalization Microscopy Array of FITC-Labeled Peptides
The uptake of synthesized FITC-labeled peptides was examined using an avian
system to validate both our wrapper based feature selection methodology and SVM-based
approach to predicting CPPs. The results of our fluorescence microscopy analysis are
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shown in Figure 3.1. All peptides predicted to be cell-penetrating (Peptide-1 through
Peptide-4) by our classifier were confirmed to be cell-penetrating. Of our two negative
predictions, Peptide-5 was confirmed to be a non-penetrating peptide while Peptide-6 was
shown to traverse cellular membranes. TP13, a CPP analog previously shown to be nonpenetrating in Bowes’ melanoma cells is clearly cell-penetrating peptide in our avian
model.

Uptake Quantification of FITC-Labeled Peptides
To evaluate the relative uptake of our synthesized peptides and to provide a
secondary confirmation of the fluorescence microscopy results, a quantitative uptake
study was conducted using both quail SOgE cells and chicken embryonic fibroblasts.
The results of the quantitative uptake study are shown in Figure 3.2. Peptides 1-4 were
shown to be CPPs, while Peptide-5 was correctly predicted to be non-penetrating.
Peptide-6, which was predicted to be non-penetrating, was shown to traverse the
membranes of both CEF and SOgE cells. TP13, previously shown to be non-penetrating
in melanoma cells, is again shown to have penetrated both CEF and SOgE cells to a high
degree relative to both our positive controls and our predicted cell-penetrating peptides.
TP13 was chosen as a non-penetrating CPP analog based on its non-CPP classification in
a study examining the effects of deletion on a known CPP, transportan (TP) [16]. TP13
was created by a deletion from the N-terminus and middle of the TP molecule and these
deletions abolished the internalization of TP13 into Bowes’ melanoma cells. All
transportan-derived peptides that internalized during the original TP analog study
contained tyrosine and 3 positive charges in their sequences, while those peptides without
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tyrosine or one positive charge in the C-terminal portion of the peptide did not internalize
[16]. TP13 contains tyrosine and 3 positive charges, meeting the criteria outlined by the
original study for penetration and both our fluorescent microscopy data and quantitative
fluorescent uptake data indicates that it does penetrate both SOgE cells and CEF cells.
Peptide-6 (HSPIIPLGTRFVCHGVT) was predicted to be a non-CPP by our
classifier, but was shown to internalize into both SOgE and CEF cells experimentally
both by fluorescence microscopy and the quantitative uptake studies. This peptide
contains 3 positively charged amino acids along with phenylalanine. The Sommets, et al.
study examining TP and its derivatives states that all their peptides with 3 positive
charges and tyrosine internalized, and as phenylalanine only lacks the hydroxyl group of
the tyrosine molecule, this could contribute to the internalization of Peptide-6. The
positive examples in our training data contain predominantly arginine and lysine as
positive residues, while this peptide contains two histidine residues.
Our research shows that using the primary biochemical properties of peptides as
features instead of composite features determined through the use of PCA can provide
both more informative features and higher classification accuracies when using support
vector machines for the classification of a given peptide as cell-penetrating. The lack of a
comprehensive and coherent database of cell-penetrating peptide data for bioinformatics
analysis has been noted previously [8], and the majority of CPP studies have been
conducted using a variety of different cell lines and detection techniques, making it
difficult to unify these results. Our results showing that a previously reported nonpenetrating analog of transportan is a CPP in our avian system confirms the need for a
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large dataset of biologically confirmed positive and negative examples from a single
biological system using a single detection methodology. Until such a resource is
available, the predictive capability of classifiers is difficult to assess. Our results also
show that there may be classes of peptides that act as CPPs in a variety of cells and others
that are more specialized. Therefore, peptides designed to target delivery to specific cells
and tissues of interest should be screened using a variety of cell lines. Additionally, our
results indicate there may be positional preference for certain types of amino acids such
as positive charges and aromatic. Further research should examine the effects of these
positional effects.

Materials and Methods

Data Set Compilation Strategy
A database of cell-penetrating peptides was constructed from the literature and
from commercial vendor product lines [7, 8, 12]. A total of 111 cell-penetrating peptide
(CPP) sequences were identified and used to create a database of positive examples
(Table 6) [7, 8, 12]. The average amino acid lengths of these CPPs ranged from 12 to 26.
Because very few peptides have been experimentally validated to be non-penetrating, it
was more challenging to construct a database of negative examples. Five different
strategies were used. Because our experimental system is avian, we have used the
composition of the chicken proteome as the basis for two of our datasets. Previous
research has demonstrated the importance of using a balanced training sets where there
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are approximately equal numbers of positive and negative examples [10]. Our strategies
are listed below:

1. BALANCED WITH RANDOM PEPTIDES: The set of 111 know CPPs
was balanced with a set of 111 peptides constructed using a 0th order
Markov chain derived from the IPI chicken proteome (ipi.CHICK.v3.56
[11]) . The peptide lengths were uniformly distributed in the range 12-26.
We assume that there is a very low probability that randomly generated
peptides would be cell penetrating.
2. BALANCED WITH BIOLOGICAL PEPTIDES: The set of 111 know
CPPs was balanced with randomly selected biological peptides. A set of
411 chicken peptides from NCBI with lengths in the range 12-26 was
downloaded. Subsets of 111 peptides were selected randomly without
replacement to provide multiple balanced datasets. This dataset provides
a set of positive examples of known CPPs and assumed negative examples
of biological peptides of the same relative molecular size. We assume that
most naturally peptides are not cell penetrating.
3. UNBALANCED USING ONLY KNOWN POSITIVES: A set of 34 known
non-penetrating cell penetrating peptide analogs and peptide hormones
previously used as negative examples was constructed from a search of the
literature and are listed in Table 3.7 [7, 8]. This dataset provides a set of
known cell-penetrating positive examples and a set of non-penetrating
peptides that have been experimentally shown not to traverse cellular
membranes.
4. BALANCED BY SAMPLING KNOWN NEGATIVES: In order to produce a
balanced dataset of both known non-penetrating peptides and known CPPs
a set consisting of all 111 known cell penetrating peptides and 111 known
non-penetrating cell penetrating analogs was constructed by selecting with
replacement from the set of 34 known non-penetrating analogs .
5. BALANCED BY SAMPLING KNOWN POSITIVES: Subsets of the known
CPPs of size 34 were selected with replacement and combined with the 34
known non-penetrating cell penetrating analogs to create ten balanced
subsets.
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Feature Construction and Normalization
For each dataset, we generate a set of basic biochemical properties of each peptide
(e.g. mass, size, charge, secondary structure, etc) and other features previously shown to
be useful in the prediction of CPPs (e.g. steric bulk and net donated hydrogen bonds) [8].
The full list of the initial 61 features is shown in Table 3.8. We use these features
directly in our machine learning algorithm rather than using composite features such as
features derived by principle component analysis [8, 17]. We feel this approach will be
more informative in the rationale design of CPPs cell penetrating peptides. Because the
data values for each feature within a dataset vary greatly, NV normalization was used to
scale the numeric range of all features in the range [0, 1] [18].

Machine Learning Software
The WEKA Machine Learning Toolkit Version 3.6.1, a freely available software
package containing a number of machine learning algorithms for data mining, was used
for feature selection, classifier construction, and classifier evaluation [19].

Feature Selection
We conducted feature selection to reduce the dimensionality of the feature
vectors. Empirical evaluation of a number of different feature selection methods was
conducted and the best performance was obtained using a wrapper-based method. The
wrapper-based method uses a parallel scatter search algorithm [13] to evaluate feature
subsets based on classifier performance. Scatter search is an evolutionary algorithm, but
unlike other evolutionary algorithms (e.g. genetic algorithms), the search for a local
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optimum is guided through the use of a reference set that acts to intensify and diversify
the resulting features [13]. Local searches of features generated from the reference set
are conducted, and informative and diverse features from these local searches are used to
update the reference set until a terminating condition is met [13].

Classifier Construction
Our classifier is a support vector machine (SVM) trained via a sequential minimal
optimization (SMO) algorithm used in conjunction with the Pearson VII universal kernel
[14, 15]. SVMs are supervised learning classifiers generally used for solving two class
problems, and in their simplest form can be thought of as a classifier separating two
classes mapped onto a 2-dimensional plane by generating a line through the plane that
optimizes the distribution of each class on either side of the line [14]. The SMO
algorithm is a modification to the original SVM learning algorithms that replaces a
numerical quadratic programming step with an analytical quadratic programming step,
allowing the algorithm to spend a greater portion of time on the decision function instead
of the quadratic programming step. This greatly increases the speed of the SVM for
classification and allows scaling for large datasets [14]. We chose to utilize SMO-based
SVM classifiers because of their speed and performance for our two class problem of
determining if given peptide is cell-penetrating or non-penetrating. A kernel function
used in conjunction with an SVM allows the classifier to examine non-linear
relationships between features by mapping the initial non-linear features into a highly
dimensional space where the solution can be represented by a linear classification [15].
We chose the Pearson VII universal kernel (PUK) for our SMO-based SVM because
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PUK has been shown to provide either equal or better mapping than traditional SVM
kernels, while serving as a robust and generic alternative to other kernel functions [15].
Accuracy for all classifiers was evaluated using 10-fold cross-validation.

Peptide Synthesis
A 0th order Markov chain based on the amino acid frequency of the IPI Chicken
Proteome (ipi.CHICK.v3.56) [11] was used to generate 250 peptides. The classifier
trained on our biologically based random peptide dataset was then used to classify each
of these peptides. From these classification results, four peptides predicted to be cell
penetrating and two peptides predicted to be non-cell penetrating were selected for
synthesis and experimental validation. In addition, three peptides known to be cellpenetrating (HIV-Tat [20], Antennapedia [21], and Pep-1 [22]) were chosen to be
positive experimental controls. Three other peptides, one of all polar amino acids, one of
all non-polar amino acids, and one of a mix of polar and non-polar amino acids, were
chosen as negative experimental controls because their lack of charged and aromatic Rgroups make it unlikely they would cross a cellular membrane. One peptide (TP13 [8,
16]) was randomly selected for synthesis from the list of known non-penetrating cell
penetrating peptide analogs. All peptides selected for synthesis are shown in Table 3.9.
Peptides were synthesized (>95% purity) and N-terminally labeled with FITC, a
fluorescent tag, by Biomatik. During the peptide synthesis, one of our chosen negative
controls, negative-2 (GLALLGIAVAILVVL-NH2) was unable to be synthesized to our
desired purity levels due to insolubility issues and is not considered further. The
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lyophilized peptides were reconstituted using 1 mL of 4:1 dd H2O sterile filtered 0.45 µm
and acetonitrile (EMD OmniSolv).

Tissue Culture
Two avian cell lines, Quail SOgE muscle cells [23] and a primary culture of
Chicken embryonic fibroblasts (CEF), were grown in tissue culture flasks in Dulbecco’s
minimal essential medium containing 10% fetal bovine serum with penicillin (200
IU/mL), streptomycin (200 µg/mL), amphotericin B (0.5 µg/mL) (MP Biomedicals), and
non-essential amino acids at 37°C in a 5% CO2 atmosphere.

Quantitative Uptake Analysis
Approximately 100,000 cells per well (both CEFs and SOgEs) were plated onto
12-well tissue culture plates approximately 2 days prior to the experiment and allowed to
reach confluency. The cells were changed to serum free media and incubated for 60
minutes prior to experimentation. The cells were then washed with two 1 mL washes of
PBS, after which they were exposed to 300 µL of 10 µM peptide in serum free media for
30 minutes, with three replicates per peptide per cell line. The cells were then washed
with two 1 mL washes of PBS, and lightly trypsinated to facilitate their detachment from
the plate. Cells were then lysed with 250 µL of 0.1% Triton-X in PBS at 4° C for 10
minutes. A 100 µL aliquot of the cell lysate and a 100 µL aliquot of the 10 µM peptide
in serum free media were pipetted onto a 96-well plate. Fluorescence was measured on a
Dynex Fluorolite 1000 plate reader at 485/530nm. The samples were compared to the
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fluorescence of the added amount of peptide and t-tests (p > 0.05) were performed for
each experimental sample against an untreated control.

Cellular Internalization Microscopy Array of FITC-Labeled Peptides
The SOgE cells were seeded onto glass tissue microscopy slides (approximately
50,000 cells/well), and allowed two days to reach confluency. The cells were changed to
serum free media and incubated for 60 minutes prior to experimentation. The cells were
then washed with two 1 mL washes of PBS, after which they were exposed to 300 µL of
10 µM peptide in serum free media for 30 minutes. The cells were then washed with two
1 mL washes of PBS, and then fixed using UltraCruzTM Mounting Medium (Santa Cruz
Biotechnology) containing a DAPI nuclear stain. The fluorescence was examined using a
Nikon Eclipse TE2000-U Inverted Research Microscope with the MetaMorph
microscopy imaging software.
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TABLE 3.1
CONFUSION MATRICES FOR DATASETS GENERATED USING DIFFERENT
APPROACHES.
Dataset 1. Unbalanced (total examples 145).
NonCPP

CPP

 Classified as

0

34

Non-CPP

1

110

CPP

Dataset 2. Balanced with random peptides as negatives.
A. 10-fold cross-validation with training data (total examples 222).
NonCPP

CPP

 Classified as

109

2

Non-CPP

7

104

CPP

B. Tested on unbalanced data (total examples 145).
NonCPP

CPP

 Classified as

12

22

Non-CPP

6

105

CPP
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TABLE 3.1 continued
Dataset 3. Balanced with biological peptides as negatives.
A. 10-fold cross-validation with training data (total examples 222).
NonCPP

CPP

Classified as

108

3

Non-CPP

10

101

CPP

B. Tested on unbalanced data (total examples 145).
NonCPP

CPP

 Classified as

10

24

Non-CPP

6

105

CPP

Dataset 4. Balanced by sampling known negatives.
A. 10-fold cross-validation with training data (total examples 222).
NonCPP

CPP

 Classified as

96

15

Non-CPP

10

101

CPP

B. Tested on unbalanced data (total examples 145).
NonCPP

CPP

 Classified as

29

5

Non-CPP

7

104

CPP
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TABLE 3.2
CLASSIFIER PERFORMANCE WITH DIFFERENT TRAINING REGIMES.
a.

Performance from ten-fold cross validation with training data sets.
Unbalanced

Balanced with
random
negatives

Balanced with
biological
negatives

Balanced by
sampling from
known negatives

Balanced by
sampling from
known
positives*

Accuracy

75.86%

95.94%

94.14%

88.73%

78.82%

True Positive
Rate

0.759

0.959

0.941

0.887

0.7883

False Positive
Rate

0.768

0.041

0.059

0.113

0.2117

ROC

0.495

0.959

0.941

0.887

0.7883

*- These values represent the averages for 10 datasets. .
b.

Performance of each classifier with original dataset.
Unbalanced

Balanced with
random
negatives

Balanced with
biological
negatives

Balanced by
sampling from
known negatives

Accuracy

75.86%

80.69%

79.31%

91.70%

True Positive
Rate

0.759

0.807

0.793

0.917

False Positive
Rate

0.768

0.508

0.553

0.127

ROC

0.495

0.649

0.620

0.895
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TABLE 3.3
COMPARISON OF SVM BASED CPP CLASSIFIERS TO PREVIOUSLY
PUBLISHED METHODS.
Hällbrink2005 [7]

Hansen2008 [8]

Dobchev2010 [9]

Unbalanced

Distributionbased

Biologicallybased

Balanced
by sampling
Non-CPPs

Overall
Accuracy

77.27%

67.44%

83.16%

75.86%

80.69%

79.31%

91.72%

CPP
Accuracy

88.46%

80.30%

92.21%

99.10%

94.59%

94.59%

93.69%

Non-CPP
Accuracy

35.71%

25.00%

54.17%

0.00%

35.29%

29.41%

85.29%
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TABLE 3.4
FEATURES SELECTED FOR DATASETS GENERATED
USING APPROACHES 1-4.
Dataset 1

Dataset 2

Dataset 3

Dataset 4

(Balanced with random
negative examples)

(Balanced with biological
peptides assumed to be
negative)

(Unbalanced dataset)

(Balanced by random
sampling of known negatives
with replacement)

Net Charge

Net Charge

Net Charge

Negative Charge

Positive Charge

Isoelectric Point

Positive Charge

Isoelectric Point

Number of serines (S)

Molecular Weight

Number of alanines (A)

Number of glycines (G)

Number of aspartates (D)

Hydropathicity

Number of arginines (R)

Number of alanines (A)

Percent valine (V)

Number of valines (V)

Percent arginines (R)

Number of tryptophans (W)

Percent proline (P)

Number of lysines (K)

Net Donated Hydrogen
Bonds

Number of asparagines (N)

Percent phenylalanine (F)

Number of arginines (R)

Number of lysines (K)

Percent threonine (T)

Percent glycine (G)

Number of histidines (H)

Percent asparagine (N)

Percent methionine (M)

Number of aspartates (D)

Percent tyrosine (Y)

Percent tyrosine (Y)

Percent phenylalanine (F)

Percent cysteine (C)

Percent cysteine (C)

Percent tryptophan (W)

Percent arginine (R)

Percent aspartate (D)

Percent arginine (R)

Percent histidine (H)

Percent negative

Percent histidine (H)

Percent aspartate (D)

Water Octanol Partition
Coefficient

Percent Hydrophobic

Percent negative

Net Donated Hydrogen
Bonds

Percent negative

Steric Bulk

Percent Helix

Hydrophobicity

Net Donated Hydrogen
Bonds

Percent Coil

Water Octanol Partition
Coefficient

Percent Helix
Percent Coil
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TABLE 3.5
FEATURES SELECTED FOR TEN DATASETS GENERATED USING APPROACH 5
– BALANCED SUBSETS OF CPPS SAMPLED WITH REPLACEMENT COMBINED
WITH KNOWN-CPP ANALOGS.
Dataset 1

Dataset 2

Dataset 3

Number (V)

Length

Number (R)

Percent (R)

Net Charge

Percent (W)

Number (V)

Percent
positive

Number (C)
Percent (H)
Net
Donated
Hydrogen
Bonds

Amphipacity
Percent
Helix

Dataset 4
Net
Charge
Negative
Charge

Number
(I)
Number
(H)
Percent
(F)
Net
Donated
Hydrogen
Bonds

Dataset 5

Dataset 6
Percent
(T)
Percent
(Y)
Net
Donated
Hydrogen
Bonds
Percent
Sheet

Net Charge
Percent (I)

Hydrophobicity
Net Donated
Hydrogen Bonds

Dataset 7
Net Charge
Positive
Charge

Dataset 8
Positive
Charge
Number (G)

Percent (I)

Number (S)

Percent (W)
Percent
Hydrophobic

Percent (F)
Percent (R)

Percent (H)
Amphipacity
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Dataset
9
Number
(W)
Number
(T)

Number
(R)
Percent
(S)
Percent
(T)

Dataset 10
Positive
Charge
Percent (I)

Amphipacity

TABLE 3.6
KNOWN CELL-PENETRATING PEPTIDES FROM THE LITERATURE AND
COMMERCIAL VENDORS.
Cell-penetrating peptide
AAVALLPAVLLALLAKNNLKDCGLF
AAVALLPAVLLALLAKNNLKECGLY
AAVALLPAVLLALLAPVQRKQKLMP
AAVALLPAVLLALLAVTDQLGEDFFAVDLEAFLQEFGLLPEKE
AAVLLPVLLAAP
AGYLLGKINLKALAALAKKIL
AGYLLGKLKALAALAKKIL
AHALCLTERQIKIWFQNRRMKWKKEN
AHALCPPERQIKIWFQNRRMKWKKEN
ALWKTLLKKVLKA
AYALCLTERQIKIWFANRRMKWKKEN
CGPGSDDEAAADAQHAAPPKKKRKVGY
CNGRC
CNGRCG
CNGRCGGKKLKLLKLL
CNGRCGGKLAKLAKLAKLAK
CNGRCGGLVTT
GAARVTSWLGRQLRIAGKRLEGRSK
GALFLGFLGAAGSTMGAWSQPKSKRKV
GGRQIKIWFQNRRMKWKK
GIGKFLHSAKKWGKAFVGQIMNC
GLAFLGFLGAAGSTMGAWSQPKSKRKV
GRKKRRQ
GRKKRRQRRPPQC
GRKKRRQRRRC
GRKKRRQRRRPPC
GRKKRRQRRRPQ
GRQLRIAGKRLEGRSK
GWTLNPAGYLLGKINLKALAALAKKIL
GWTLNPPGYLLGKINLKALAALAKKIL
GWTLNSAGYLLGKINLKALAALAKKIL
GWTLNSAGYLLGKINLKALAALAKKLL
GWTLNSAGYLLGKLKALAALAKKIL
GWTLNSKINLKALAALAKKIL
INLKALAALAKKIL
IWFQNRRMKWKK
KALAALLKKWAKLLAALK
KALAKALAKLWKALAKAA
KALKKLLAKWAAAKALL
KCRKKKRRQRRRKKLSECLKRIGDELDS
KCRKKKRRQRRRKKPVVHLTLRQAGDDFSR
KETWWETWWTEWSQPKKKRKV
KETWWETWWTEWSQPKKRKV
KFHTFPQTAIGVGAP
KITLKLAIKAWKLALKAA
KIWFQNRRMKWKK
KLAAALLKKWKKLAAALL
KLALKALKALKAALKLA
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Reference
[12]
[12]
[12]
[12]
[8, 12]
[7, 8]
[8]
[8]
[8]
[7]
[8]
[8]
[12]
[12]
[12]
[12]
[12]
[7]
[12]
[7]
[12]
[8]
[7]
[8]
[7, 8]
[7, 8]
[7, 8]
[7]
[7, 8]
[7, 8]
[7, 8, 12]
[7, 8]
[7, 8]
[8]
[12]
[8]
[8]
[7, 8]
[7, 8]
[7]
[7]
[12]
[8]
[8]
[7, 8]
[8]
[7, 8]
[7, 8]

TABLE 3.6 continued
KLALKLALKALKAALK
KLALKLALKALQAALQLA
KLALKLALKAWKAALKLA
KLALQLALQALQAALQLA
KMTRAQRRAAARRNRWTAR
KRPAATKKAGQAKKKKL
LGTYTQDFNKFHTFPQTAIGVGAP
LIRLWSHLIHIWFQNRRLKWKKK
LKTLATALTKLAKTLTTL
LKTLTETLKELTKTLTEL
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESC
LLIILRARIRKQAHAHSK
LLIILRRPIRKQAHAHSK
LLIILRRRIRKQAHAHSA
LLIILRRRIRKQAHAHSK
LNSAGYLLGKINLKALAALAKKIL
LNSAGYLLGKLKALAALAKIL
MANLGYWLLALFVTMWTDVGLCKKRPKP
MDAQTRRRERRAEKQAQWKAAN
MGLGLHLLVLAAALQGAKKKRKV
MPKKKPTPIQLNP
MVKSKIGSWILVLFVAMWSDVGLCKKRPKP
MVTVLFRRLRIRRACGPPRVRV
NAKTRRHERRRKLAIER
PKKKRKV
PKKKRKVALWKTLLKKVLKA
PMLKE
QLALQLALQALQAALQLA
RGGRLSSYSRRRFSTSTGR
RGGRLSYSRRRFSTSTGR
RGGRLSYSRRRFSTSTGRA
RKKRRQRRR
RKSSKPIMEKRRRAR
RQARRNRRRALWKTLLKKVLKA
RQGAARVTSWLGRQLRIAGKRLEGR
RQGAARVTSWLGRQLRIAGKRLEGRSK
RQIKIWFPNRRMKWKK
RQIKIWFQNMRRKWKK
RQIKIWFQNRRMKWKK
RQIKIWFQNRRMKWKKLRKKKKKH
RQIRIWFQNRRMRWRR
RQPKIWFPNRRMPWKK
RRLSSYSSRRRF
RRMKWKK
RRRRRRRRR
RRWRRWWRRWWRRWRR
RVIRVWFQNKRCKDKK
RVTSWLGRQLRIAGKRLEGRSK
SWLGRQLRIAGKRLEGRSK
TAKTRYKARRAELIAERR
TRQARRNRRRWRERQR
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[7, 8]
[8]
[7, 8]
[8]
[7]
[7]
[8]
[8]
[8]
[8]
[8]
[7]
[7]
[7]
[7, 8]
[7, 8]
[8]
[8]
[7, 12]
[7]
[12]
[8]
[8]
[7, 12]
[12]
[7]
[8]
[8]
[8]
[7]
[12]
[7, 8]
[7]
[7]
[7]
[7]
[7, 8]
[8]
[7, 8, 12]
[7]
[8, 12]
[8]
[8]
[8]
[7, 8, 12]
[8]
[7, 8]
[7]
[7]
[7, 12]
[8]

TABLE 3.6 continued
TRRNKRNRIQEQLNRK
TRSSRAGLQFPVGRVHRLLRK
TRSSRAGLQWPVGRVHRLLRKGGC
VPALR
VPMLK
VPTLK
VQAILRRNWNQYKIQ
VRLPPPVRLPPPVRLPPP
WFQNRRMKWKK
YGRKKRRQRRR
YGRKKRRQRRRGTSSSSDELSWIIELLEK
YGRKKRRQRRRSVYDFFVWL

[7, 8, 12]
[12]
[12]
[8]
[8]
[8]
[7]
[8]
[8]
[12]
[7]
[7]
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TABLE 3.7
KNOWN NON-PENETRATING CELL-PENETRATING PEPTIDE ANALOGS AND
PEPTIDE HORMONES.
Non-cell penetrating peptide
AGCKNFFWKTFTSC
AHALCLTERQIKSNRRMKWKKEN
CYFQNCPRG
DFDMLRCMLGRVYRPCWQV
EILLPNNYNAYESYKYPGMFIALSK
FITKALGISYGRKKRRQC
FVPIFTHSELQKIREKERNKGQ
GRKKRRQPPQC
GWTLNSAGYLLGKFLPLILRKIVTAL
GWTLNSAGYLLGKINLKAPAALAKKIL
GWTLNSAGYLLGPHAI
GWTNLSAGYLLGPPPGFSPFR
HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGR
IAARIKLRSRQHIKLRHL
ILRRRIRKQAHAHSK
KIWFQNRRMK
KKKQYTSIHHGVVEVD
KKLSECLKRIGDELDS
KLALKALKAALKLA
KLALKLALKALKAA
LLGKINLKALAALAKKIL
LLKTTALLKTTALLKTTA
LLKTTELLKTTELLKTTE
LNSAGYLLGKALAALAKKIL
LNSAGYLLGKLKALAALAK
LRKKKKKH
PVVHLTLRQAGDDFSR
QNLGNQWAVGHLM
RPPGFSPFR
RQIKIFFQNRRMKFKK
RQIKIWFQNRRM
RQIKIWFQNRRMKWK
TERQIKIWFQNRRMK
WSYGLRPG
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Reference
[7]
[8]
[7]
[7]
[7]
[8]
[7]
[8]
[7, 8]
[7, 8]
[7]
[7]
[7]
[8]
[8]
[8]
[7]
[7]
[7, 8]
[8]
[8]
[7, 8]
[7, 8]
[7, 8]
[7, 8]
[7]
[7]
[7]
[7]
[7, 8]
[8]
[8]
[8]
[7]

TABLE 3.8
A LIST OF INITIAL FEATURES USED FOR CLASSIFIER CONSTRUCTION.
Feature
Length of peptide
Net charge of peptide
Positive charge
Negative charge
Isoelectric point (pI)
Molecular weight
Hydropathicity
Number of Each Amino Acid (20 features)
Percent composition of each amino acid (20 features)
Percent polar amino acids
Percent positive amino acids
Percent negative amino acids
Percent hydrophobic amino acids
Hydrophobicity
Lipophilicity
Amphiphilicity
Water-Octanol Partition Coefficient
Steric Bulk
Side chain bulk
Net donated hydrogen bonds
Percent α helix
Percent random coil
Percent β sheet
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Reference
[24]
[24]
[24]
[24]
[24]
[24]
[25]
[24]
[24]
[24]
[24]
[24]
[24]
[25]
[26]
[27]
[25]
[25]
[8]
[8]
[28]
[28]
[28]

TABLE 3.9
PEPTIDES SYNTHESIZED FOR EXPERIMENTAL VALIDATION OF CLASSIFIER.
Name

Role

Sequence (N to C)

HIV-TAT [20]

Control(+)

YGRKKRRQRRR-NH2

Antennapedia
[21]

Control(+)

RQIKIWFQNRRMKWKK-NH2

Control(+)

KETWWETWWTEWSQPKKKRKVNH2

negative-1

Control(-)

TCSSNCQTCPCSSNNCQ-NH2

negative-2*

Control(-)

GLALLGIAVAILVVL-NH2

negative-3

Control(-)

PGNIQMMSVVSMSMTITN-NH2

peptide-1

Predicted CPP

FKIYDKKVRTRVVKH-NH2

peptide-2

Predicted CPP

RASKRDGSWVKKLHRILE-NH2

peptide-3

Predicted CPP

KGTYKKKLMRIPLKGT-NH2

Predicted CPP

LYKKGPAKKGRPPLRGWFHNH2

peptide-5

Predicted Non-CPP

FFSLPPVTQDWNSD-NH2

peptide-6

Predicted Non-CPP

HSPIIPLGTRFVCHGVT-NH2

TP13 [8, 16]

Known Non-CPP-CPP
Analog

LNSAGYLLGKALAALAKKILNH2

Pep-1 [22]

peptide-4

Footnote: *negative-2 was unable to be synthesized to desired purity levels due to
insolubility issues.
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Figure 3.1
Cellular Internalization Microscopy Array of FITC-Labeled Peptides
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Figure 3.2
Quantitative Uptake Analysis
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CHAPTER IV
THE PROTEOGENOMIC MAPPING TOOL

Abstract

Background
High-throughput mass spectrometry (MS) proteomics data is increasingly being
used to complement traditional structural genome annotation methods. To keep pace
with the high speed of experimental data generation and to aid in structural genome
annotation, experimentally observed peptides need to be mapped back to their source
genome location quickly and exactly. Previously, the tools to do this have been limited
to custom scripts designed by individual research groups to analyze their own data, are
generally not widely available, and do not scale well with large eukaryotic genomes.

Results
The Proteogenomic Mapping Tool includes a Java implementation of the AhoCorasick string searching algorithm which takes as input standardized file types and
rapidly searches experimentally observed peptides against a given genome translated in
all 6 reading frames for exact matches. The Java implementation allows the application
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to scale well with larger eukaryotic genomes while providing cross-platform
compatibility.

Conclusions
The Proteogenomic Mapping Tool provides a standalone application for mapping
peptides back to their source genome on a number of operating system platforms with
standard desktop computer hardware. Researchers are provided with the options for
selecting different genetic codes and selecting different methods for determining splice
sites. The program executes very rapidly across a wide range of datasets and enables
researchers to structurally annotate genomes using MS derived proteomics data in
standard format.

Background
Expressed proteins provide experimental evidence that genes in the genome are
being transcribed and translated to produce a protein product. Recently, a new structural
genome annotation method, proteogenomic mapping, has been developed that uses
identified peptides from experimentally derived proteomics data to identify functional
elements in genomes and to improve genome annotation [1-2]. Initially used for the
structural annotation of prokaryotic genomes, proteogenomic mapping is rapidly gaining
traction in eukaryotic genome annotation projects with larger genomes as a
complementary method [3-4].
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Proteogenomic mapping can identify potential new genes or corrections to the
boundaries of predicted genes by using peptide matches against the genome that do not
match against the predicted proteome to generate expressed Protein Sequence Tags
(ePSTs) [2]. When aligned with the genome and combined with the published structural
annotation, these ePSTs are indicative of translation throughout the genome and can
serve to supplement traditional structural genome annotation methods [3-5].
While a number of research groups are becoming increasingly active in the field
of proteogenomic mapping [1-5], there is a lack of published and standardized tools to
rapidly and exactly map identified peptides back to the genome translated in all 6 reading
frames. To our knowledge, there is only one comparable tool, PepLine [6], for
proteogenomic mapping. PepLine utilizes de novo based spectral identification based on
short spectral match translations of 3-4 amino acids with flanking masses on either end
for searches against the genome. In contrast, our tool enables the researcher to use the
same database search algorithm and peptide validation approach for both protein
identification and improved genome structural annotation.

Implementation
The Proteogenomic Mapping Tool is free to obtain and use, is written completely in Java,
and is available for all common computer platforms. It is licensed under GNU GPLv3
making the source code available to the end user [7]. We provide both a command line
version and a graphical user interface (GUI) for all common platforms.
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Data Input and Customization
The GUI (Figure 1) takes three files as input from the user: a FASTA file of the
peptides to be searched, a FASTA file containing the nucleic acid sequences the peptides
are to be mapped against (typically the genome), and a file containing the genetic code to
use based on the format of the National Center for Biotechnology Information’s (NCBI)
toolkit for genetic codes [8]. Furthermore, FASTA output from the splice site prediction
tool GeneSplicer [9] can optionally be provided. If present, the splice sites given in that
file are used instead of the default splice sites for generation of ePSTs. The user is also
required to provide a file name and location for the three output files that will be
generated.
To generate the FASTA file of the peptides to be searched, it is expected that the
user will have performed spectral matching of their MS dataset against databases
generated from both the proteome and the genome translated in all six reading frames and
confirmed these peptide identifications using a peptide validation strategy. After
validation, the unique peptide identifications resulting from a database search against the
genome that are not contained among the proteome peptide identifications should be used
as the list of peptides to be searched.
The command line version of the Proteogenomic Mapping Tool allows the same
inputs as the GUI to be specified as command line arguments and can be run on standard
computer platforms (Windows, Linux, Unix, MacOS). An example of using the
command line version of the program is included in the README file provided with the
application.
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The application translates the nucleotide database to protein in all 6 reading
frames using the genetic code selected by the user. We provide the most common genetic
codes from NCBI [8] which are represented in NCBI’s standard format for genetic codes
in the genetic_code_table file included with the application. The tool maps the peptides
to the translated genome using the Aho-Corasick string searching algorithm to provide
rapid and exact matches of peptides to the genome [10-11]. The Aho-Corasick string
matching algorithm [10] quickly locates all occurrences of keywords within a text string.
The algorithm consists primarily of two phases. In the first, a finite state machine is
constructed from the set of keywords. The time to construct this machine and its memory
requirements are linearly proportional to the sum of the lengths of the keywords. The
second phase consists of running the state machine using the text string as input. This
phase takes time linearly proportional to the length of the text string. Thus, the time to
run the entire algorithm is proportional to the sum of the length of the keywords and the
length of the text string. In our case, the peptides for which to search are the keywords,
and the reference genome against which to search is the text string.

ePST Generation
Once a peptide has been mapped to a nucleotide sequence, the reverse translated
peptide is used to create an expressed Protein Sequence Tag (ePST) [2]. Figure 2
illustrates the ePST generation process for prokaryotes and Figure 3 shows both options
for the ePST generation process in eukaryotes. For prokaryotes, the reverse translated
peptide is extended in the 3’ direction to an in-frame stop codon. In the 5’ direction, the
first in-frame stop-codon upstream of the peptide (5’ stop) is identified and the peptide is
81

extended to the first in-frame start downstream from this 5’ stop before the start of the
peptide. In the case that no in-frame start occurs between the 5’ stop and the start of the
peptide, the start of the peptide is used as the start of the ePST. The process is more
complex for eukaryotes due to splicing. For eukaryotes, the peptides can be extended to
produce ePSTs using three different approaches. In the first approach, the peptide is
extended downstream to the first in-frame stop or splice site signal [12] and upstream
until the first in-frame start, in-frame stop, or splice site signal. We have found that this
approach often generates ePSTs that are far longer than typical exons. We speculate that
this is because the potential new ORFs identified by this approach do not have a
canonical splice site signal. While the application does default to using canonical splice
site signals, our second approach includes the option of using predictions from
GeneSplicer [9], a computational splice site prediction tool. The user can select to input
GeneSplicer output for use instead of the canonical splice site signals. A third option is
to extend the peptide upstream and downstream by a nucleotide length specified by the
user given as the number of codons.
Output File Description
Three output files are produced by the application. The first file is a FASTA file
containing the ePSTs generated for the dataset. The second file is a more detailed tab
separated text file containing the original peptide identifier from the FASTA header, the
peptide sequence, the FASTA header for the nucleotide sequence containing the match,
the mapping start and end locations for the reverse translated peptide, the strand of the
nucleotide match, the reading frame of the match, the reverse translated peptide
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sequence, a longer nucleotide sequence extending from the 5’ in-frame stop codon
immediately upstream of the peptide to the 3’ in-frame stop codon immediately
downstream of the peptide, the ePST nucleotide sequence and the start and stop locations
of the ePST on the nucleotide sequence, the length of the ePST, and the translated ePST.
The third file is a GFF3 file containing the ePSTs generated for the dataset to provide
researchers with a file format they can quickly load into genome browsers for data
visualization.
Example Datasets
To test our implementation we acquired previously published proteogenomic
mapping datasets for a number of organisms. For a relatively small example data set, we
selected a proteogenomic mapping dataset for the channel catfish virus [5]. This small
dataset contains 407 unique peptide identifications, of which 17 peptides did not map to
the predicted proteome of the virus, but do map to novel open reading frames in the viral
genome. The expression of several of these genes was confirmed by RT-PCR [5]. Our
example dataset consists of a FASTA file of these 17 peptides and the reference genome
(NC_001493.1) for the channel catfish virus. For bacterial examples, proteomics datasets
from three different microorganisms [13] were used to test our application: Histophilus
somni strain 2236, Mannheimia haemolytica strain PHL213, and Pasteurella multocida
strain 3480. For a eukaryotic example, a previously published proteomics dataset
generated from chicken serum was utilized for testing [14]. Table 1 details the number of
unique peptides and the number of unique peptides mapping uniquely to the genomic
database search contained in each of these five datasets.
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Results and Discussion
The output from the Proteogenomic Mapping Tool matches the previously
published results against the CCV test dataset [5], and our output provides additional
information that not only places the mapped peptides on the appropriate nucleotide strand
but also includes the reading frame in which the match occurs. Table 2 gives a list of the
peptides and corresponding ePSTs for this dataset. We have also successfully tested this
tool for proteogenomic mapping in previously published bacterial [13] and eukaryotic
datasets [2, 14]. Table 3 provides runtime analysis for each of our five test datasets, and
demonstrates that the Proteogenomic Mapping Tool scales well for increasingly large
datasets.
Possible future updates to this application include parallelization of the searches
against the genome in all 6 reading frames, and the introduction of better thread support
to improve performance further on today’s modern increasingly multi-core processors.

Conclusions
The Proteogenomic Mapping Tool is a standalone program that facilitates a
streamlined mapping of peptides to a target genome for structural genome annotation
through the use of proteomics. This software can be used on a variety of current
operating systems and is its ability to use a variety of genetic codes makes it easily
customizable for researchers performing proteogenomic mapping in a variety of
prokaryotes, eukaryotes, and viruses.
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Availability and Requirements
Project name: The Proteogenomic Mapping Tool
Project home page: http://www.agbase.msstate.edu/tools/pgm/
Operating system(s): Windows XP, Vista (x86), Vista(x64), Linux, MacOS
Programming languages: Java
Other requirements: Java
License: GNU GPLv3 [7]
Any restrictions to use by non-academics: None
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TABLE 4.1
EXAMPLE DATASET STATISTICS.
Channel
catfish virus
Number of
unique
peptides
Number of
unique
peptides
mapping
exclusively
to genome

407

17

H. somnus
2236

M.
P. multocida G. gallus
haemolytica
3480
serum
PHL213
958
1,755
675
1,447

305

1,585

88

376

92

TABLE 4.2
CHANNEL CATFISH VIRUS PEPTIDES AND ePSTS.
ID
Proteinase-1

Peptide
NLDLLDNSTG

Reading Frame
+1

Proteinase-2

LMPCSMSS

+1

Proteinase-3

PSPVSSHPLAASVSGPC

-1

Proteinase-4

MRELVSM

+3
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ePST
CTGCTGACCAGGCTACTGTTTGTATGCACAAT
CTTGACCTTCTCGACAATTCCACTGGTGCTCCA
CAAGGGGATCTCACCGATCCAAGAGAAGATG
GGTAGG
ATGATCCGGACGAGGTTCCTAGTTCGAAGAGA
GGGCCTTCTCGATGTGGTCTCTCCCGGTGAACT
CTTCTCCGGAGAACACGGGGTAATCACCCCCG
GGACTGAACGATATAGACTCATGCCATGTTCC
ATGTCCTCTATTTGAT
GTGATTCTTCGTCTTTCCGAGCCCCGTATCGTC
GCACCCATTAGCCGCTTCGGTGAGTGGACCTT
GTGTCGCAGACATCTTCAAGACAAGCGATTGG
TTCAGATGGTGGAATTGGAATGAATATTCGCG
TATATTCACCAGTGTCTTTTAAT
TTGATGTTTTTGTTCCCGTCTCTATATCTTTATT
CAGAGTCTGAACCAGTGACACTTAGATTGTTA
TCATATGATTTAAACCATGATAGGTCACCATC
TGTAAATTCCTCATGGTTCATGATCCCGTGCTT
GGCACATATCATTATCAGAAGGATGGCCTTCA
TCGACAGCTCCACTCTCTGGTGGTCTCTGTCAC
TCACCGGCGTGCCCGGGGTCGCGTATTCCACC
GCCGTGTCTCTGTTCAAGACGGCGAGTTGGCC
TCTGGGGATATCGGCCGCCGTGACGGTCAGGG
AGTTGATGAGAGAACTGGTCTCCATGTCAGTG
TTTAGTCTCTGGAAGATTTCCTCAGCGGACATC
TCGGGTCCCGCTGCTAATGCGAGCCTCAGGGT
TTCACGGGTAATCGATAGATGCACCCGCTTGT
GGCTATGCCGGGCGGCCGGCCTCTTTCCTCGT
ACACGCGGGGTTGGTTTGGGTTCGGCCACGTG
CGCGCCCCGGCGTTCCAGTAACGTAACCGGAC
GCCTCGAGGGGACCCGCGCGGGCTCGGGATCG
GCCCCGATACCACCGGCCGGGACACCGATCAG
TTCCAGTGGCCCGCCCGCAGACGGTGGGTCTT
CGTCCTCGCTCTCTTCGCTCTCCTCCTCGCTCT
CCTCCTCCTCGCCTCCACTCTCCGTCTCGCCCC
CTTGTCTATCCTCCTCGTCCTCCTCTCGGCACA
CTCCATCTCCGCGGGTGCCGTTCGAGTCCGGC
ACCGGATCGACACTCTCATCGTCACCCGATTC
CTCACTGCTGAGCTCACGACCACCGGCGTACG
ATCCGTGGTAGT

TABLE 4.2 continued
Proteinase-5

RNDIAESSCLVA

-1

Proteinase-6

ISRDSIPILF

+3

Proteinase-7

QAVVPMNTF

-2

Proteinase-8

QLGDGPLGGGHVDHIPF

+3

Proteinase-9

ARDLPRRF

+2

Proteinase-10

EVVILQ

-1

Trypsine-1

IPFVSGLMNAQIILFSGPCMIGRNAAVSCK

+3
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TTGATGACGTCCCAGTTCGCCAGGTCGGGTCTC
ACCATCGAGAGAAACGACATCGCAGAATCCAGC
TGTCTGGTCGCGACCATCGACTCCATGGCCTCG
GCGAGACTCGTTCCTTGAT
ATGCTGACACACACCACCCCGAACAAGGCTGTA
CGTATCAGGTGCATCAAACCCAGGATACTCGCG
GGGGGTGTTCCGGGTGTAGCTCTCACTACATAC
CGAAATTTTCCGAGGTCGGAGAGGTCGCTGCAG
CTGTTGTGCTTGGTGCCGGATTGTGTGGCCCCCT
TACCGGTACTGTTGACAGTCAGCGTTCCGAACT
CGGTGAATTCGGTACTGTTGTACACAGACCACA
GGCAGTTGACAGGGAAGACCTTCCCGGGTTCTC
TCTTTTCGGGTATCTCTAGGGATTCAATCCCAAT
CTTGTTCAACCACTCGATGAAGGTGGTGGGTCC
CTGTTGGTTGTAGA
CTGTGCGTCAGTTGCTGTAACTTGACATCCGGGT
TATCGGTTGGTTTCACCGATAGATCGACCGTGA
ACGGACCCGGGGGTAAATCGGCGGGCGCGACCT
GCAGGGCCGCTCCGCAAGCGGTCGTCCCCATGA
ATACGTTCGAGCATATCACCGCCACATGTGCGT
CCTCGAGGTAGT
ATGTAGATGACCATGTCCAACTTGAGAGGTCCA
ATGTCTACCCCCCGTGGGTCGTGGTACAGAATG
TGTGTGTTGTACATGTTCGTTATGAAGTTGATTC
CATTGTCTCGGAACGCGACGGCGAGCGAGATGA
GTTGTTTCAGGATCACGGCCCCCAGGAGGGTTC
CATCGTCCGTCTCGCCATCGAAGTTCAGCTCGGT
GATGGACCTCTTGGCGGGGGTCACGTAGATCAT
ATACCTTTTCGTGCCATGGGCGCCCAGGGTGTA
GTGGAACACCGGTACCACATATGGGATAGATTT
TTGGATCGCCTGGATCCCCTCCATCAAAGACTGT
ATCGCCTCGAAATCAATGGTCGGTTTCAGCTCG
AGGTAGACGATGTCATACGTAGGGGAGAATTCG
GGGGGCCTGTATACCCTGATCTCCTTCACGCCGT
ACTCTTTGGTGGCCACGACCGGGTACACGGAGA
CGAGGTCCCGGGGGGTGAGGGTTATCAGTTTCT
TCGCGGTGTGATCATCGCCCATGTCTGCGCGCG
CAAGCCATGGCATGTATAGC
CTGTGAACAAATATATCTTCGAAGTTTGCCGCG
AGGGTACCGACGAGGTCCCGCACGCGATCTACC
AAGACGGTTTCCAGGACGTGTCTCACGACTGGA
AGGGCCGGGCCCGGCCATATCACCACGATCGAA
CCCGGGTCGAGCGCGCACTCGATAGA
ATGCGTACACCGCATACGCCTTCAGCACTGCAC
TGTCACGGCTCAGGTCCCATTTACGACGTGCGG
GGTAAGGCCTGTCTCCCTTCAGAAATTGCGTGA
GCTCGTAGTATTCGCTCAGCACCCTCTGTCCCAG
GAACTGGCGTATCCGAGGACAACCACCCCTCGA
ATGGTACACGTGTTCGTCCAGGAAATCATCGAC
GAGCGTGAAGCGGATGACCTTGACACCGCAGTC
TGGACACACGTGACGATCGCTCTTCACATCGTC
CGGGATCAAACCTCCCTTGGGTCCGAAGTACAG
TCTCGTCATGAACACGAGGTTGTCATCCTGCAA
GGTACCGTGGGCGACTATTGTATCGTAATCCAA
GGTAACATCGCAAAACCACACACCTCCGTCCGC
ACGCCATCCGCTTGGCTTGAGCATTCCCCTGGGT
GCCGCGGACCATCTGAACCCCCTGTCCGTGGGG
TTGCTGACCCGCTCACCGTCTGTCACCAGGGAA
CCGCATTCGAAATCCATCGCCTCAGTAGTGGAT
TGTCAGAGATCGTTCTATGGGTATCTGGTCAGTG
TGAATTATTGGAATGGGCGCTCGCAGTATTCTTC
AATCGTTCTTTTTCGGGCACCATGAGACTCTCGG
GATCGAGGAAGCCGCCGGCGGTCCACCGGATGC
GACACGTGAGATCCGATAACCTATAAA
CTGACAGCCACGGAATCATCGGGGGTGTACACA
ACTTCCGAATCCACGGAGTCCATCACCGCGGTG
GCGATCCCGACCATCGCACGGAGTTCGGCCTCG
GTCCCGATCTTCTCAAGGAAAAAACCAAGGTGT
TCCGGGTATACCTTTAGAATTCCCTTCGTTTCCG
GGTTGATGAACGCGCAGATCATCTTGTTCTCGG
GTCCTTGTATGATAGGCAGGAACGCGGCCGTCT
CGTGCAAGCTATCGAAACGATCCATATCATGGG
CACCGCCGATGAGATCCATCCCGATGTTCTTGC
GGAGTGCATCCATTTCGCTCACAAGAAGATAAA

TABLE 4.2 continued
Trypsine-2

ARTVFLNVRPGWSR

+3

Trypsine-3

EGQAQRTCAYPSAGLLQASQGR

+3

Trypsine-4

PCSRTSGSGACSGR

-1

Trypsine-5

NRTRVYTMPGWR

-2

Trypsine-6

LKSPPGLRK

-1

Trypsine-7

VARGEDATCPNDKGSEPR

+3
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GTAGAGGAGGGCCCGAACCGTCTTCCTAAATGT
GAGACCGGGGTGGTCTCGGAAGGACGACGCGTC
AGTCGGGCAACCCGCCATCGTACCGGCCAAGAG
GGACTTGACACAGGTGCGGATCATTCCCACCTT
GTATCCGATCTGGATCGCCCCCTGTGTGACCTGG
TTGGTCAGGCTCATGATCTGTTGGTACCACTGCT
GGTACGCCATCACTTCCCCGAGGCGCTCGTTGG
TCGTCGTACCCAGCTCCTTCAGGCCAGTAGCTA
AACGCTTGAAGTTTGTATCCATGGCCAGCATCT
GGAGGTTTATCTGGTTTTGTAGGTCGTCCACCCT
CCCGTTCACTGCCCTGATGTTGCGGTCTAACTTG
GCCGATATCAGGGCGATACTGTCTCCCAGTTCC
GTGATCACATCCGCGGTCTTGTCCAATTGTGCCT
GTAAACCGTCTATTTTGGAGGCTGCCAATGTGG
CGACCGCCAGTGCTGCCGTCGACGCGACGAGTG
CCGCGCTGGACATGGTTATCGCGGCCACCGATA
ACCCGAATTTATCGCTCGTGGGCACCGATCCGC
CCGAGGCGGGCGCGAACATCTTAACCTTTTCGT
GTTCGAGGTCCAGGTCAACGAGGCTATTTTTCA
ATAGTTCGTTACTCCGCTGGAAGTCCAGGAGTA
TCGCCGCCGTCTGAT
CTGTGAAGCCGGCCGTGAGGGACAAGCGCAAC
GAACATGTGCCTACCCCAGCGCTGGTTTACTTCA
AGCATCACAAGGCCGAGCTGGCCAAGGCGCTGG
TTGAG
CTGCGTAAGACGGAGGAGACCGTGCTCGCGGAC
GAGCGGTTCCGGGGCCTGCTCGGGCCGGAGATG
GTGGCACGGCTATTGAA
TTGGGTATCAGCTTCCGTCCGCCCCCGGAGCCG
CACTCGGGACACTCCCGGGGGGTGCAGAAGAA
ACAGAACACGTGTTTACACGATGCCCGGTTGGA
GGGAAACACGGCCTCCCCCTGGCAGAAACAACA
CGGAAAGACTGGAGACATGAT
CTGGAAAGGCTGAAAAGTCCACCGGGACTGCGA
AAGTGAC
CTGGAAACAGAACTTCTCGAGGCCATCCGAGAC
GGTGTCGCGGGTGAAGAGTTTCGCGTGGCAGCC
CCTCCGCGCGGGAATGACCACGACGCTGCACTC
CAGTATCACCTCGTTGAGGCCCACATCGAGGGT
TCCGAGGCTCAGTGCACATGGTATGTCCGCTTCC
GTGAACGTCTCCACGCATCTCTTGCCGGTGTCCT
CGGACTCATCTATCCCTCCTATCATGTTCAGGTA
GACTCGGTCTTCCATGTGGACATGCCAGTAACC
GAGGACCTTGCCCATGGGGATCTGGTGCGAGTA
CTTGAGCGTGCCCGGAGCGACCTGTACCATTGT
TTGGTGGGCCTCGATCGGCTGCTGGTACTTGCGC
ATGTGCGCGGGGATGGAGGGGTCGTCGACCGGG
TCGCCCGGGGAGAAGATGCAACATGTCCCAACG
ACAAAGGTTCCGAACCCCGTGAGTGGAACCTCG
TATAGC

TABLE 4.3
RUNTIME ANALYSIS FOR EXAMPLE DATASETS.
Dataset

Genome Size

Runtime (ms)

0.1-Mb
2.3-Mb
2.8-Mb

Number unique
peptides mapping to
genome
17
305
1,515

CCV
H. somnus 2236
M. haemolytica
PHL213
P. multocida 3480
Chicken Serum

2.5-Mb
1,050-Mb

201
92

3,003
127,991

92

563
2,932
4,507

Figure 4.1
Proteogenomic Mapping Tool Windows GUI.
The proteogenomic mapping tool requires the user to provide three files and offers
several options:
a. Peptide Sequences File: a fasta formatted file specifying the peptide sequences for
which to search.
b. Genomic Sequences File: a fasta formatted file specifying the genome in which to
search for the peptides. The file can contain the entire genome as one large entry
or multiple entries containing only selected features of interest. For example, the
file may contain all exons for an organism.
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c. Output File. Two files will be created. The filename provided by the user will
contain detailed information about the mapping. An additional fasta file with
“.fasta” appended to the name provided by the user will contain the ePST
sequence in fasta format.
d. ePST Generation Process: The user is presented with four choices:
1. Ignore splice sites (prokaryotes)
2. Use splice sites (eukaryotes)—uses canonical splice junctions to

terminate ePSTs.
3. Use calculated splice sites (GeneSplicer output)
4. Fixed distance (number of codons)—generates an amino acid sequence

of the specified length in both the upstream and downstream direction.
e. Genetic Code Table File: specifies the mapping from codons to amino acids as
well as start and stop codons. The genetic code table from NCBI is provided as
the default and will typically be selected unless the user is working with an
unusual organism. Once the Code Tables file has been selected, the codon table
names appearing in this file will be presented as options and the user should select
the appropriate codon table (Standard would be used by most researchers. If the
user provides the name of a file a different table in NCBI format, the names of all
of the codon tables specified will be listed.
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Figure 4.2
Prokaryotic ePST Generation Process.
a. Map the peptide to the translated genome.
b. Extend the mapped peptide in the 3’ direction to an in-frame stop codon.
c. Extend the mapped peptide in the 5’ direction to an in-frame stop codon.
d. From this 5’ in-frame stop codon, proceed in a 3’ direction to identify an in-frame
start codon.
e. Final ePST.
f. Generate translated ePST sequence.
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a)

b)

Figure 4.3
Eukaryotic ePST Generation Process.
a. Options 1 and 2: Map the peptide to the translated genome.
b. Option 1: Extend the mapped peptide in the 3’ direction to an in-frame stop codon
or splice site boundary. Option 2: Extend the mapped peptide in the 3’ direction
the number of codons selected by the user.
c. Option 1: Extend the mapped peptide in the 5’ direction to an in-frame stop codon
or start codon, or splice site boundary. Option 2: Extend the mapped peptide in
the 5’ direction the number of codons selected by the user.
d. Final ePST.
e. Generate translated ePST sequence.
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CHAPTER V
PROTEOGENOMIC MAPPING OF GALLUS GALLUS SERUM

Abstract
The process of using mass spectrometry derived proteomics data for genome
annotation is called proteogenomic mapping. Proteogenomic mapping can make
significant contributions to the structural annotation of genomes through the discovery of
new functional elements, confirmation of hypothetical and predicted functional elements,
corrections to the intron/exon boundaries of known functional elements, and
characterization and discovery of alternative splice forms. We use serum proteins
derived from Gallus gallus (chicken) and mass spectrometry for proteogenomic mapping
of expressed peptides to the chicken genome to improve structural annotation. We
confirm the expression of 268 proteins from chicken serum and identify an additional 47
peptides that confirm the expression of mRNA, identify novel exons or genes, indicate
expression of repeat regions, and correct the boundaries of known exons.

Background
Structural genome annotation is the process of identifying all of the structural
elements that comprise an organism’s sequenced genome. These structural elements can
include regions that code for proteins, both coding and non-coding RNAs, regulatory
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regions, and DNA binding motifs. Traditionally, this has been accomplished through the
use of expressed sequence tags (ESTs) and cDNA libraries (transcribed RNA that is
reverse translated into DNA sequences). These ESTs and cDNAs generally represent
approximately 500-800 base pair mRNA sequences that are sequenced as mRNA, or
translated back into cDNA and then sequenced [1, 2]. These EST and cDNA libraries are
then aligned with the sequenced genome to identify regions representing exons and whole
genes that are actively transcribed [1, 2].
These methods are traditionally complemented by the use of computational gene
finders that utilize the EST and cDNA libraries and the sequenced genome to identify
patterns within the genome indicative of coding regions. This is known as homology
based computational annotation [1, 2]. Additionally, these programs can perform de
novo based genome annotation where they detect signal information within the genome
and use these signals to predict coding regions [1]. These computational gene prediction
tools produce a number of errors, and significant resources are dedicated to identifying
and correcting these errors within the genome annotation [1, 3]. It is estimated that the
exact genomic structure is only correctly identified by computational gene finders 5060% of the time within the human genome, the most well sequenced and annotated
genome [3]. These errors can arise from a number of causes. Homology based
annotation identifies new genetic sequences based on their similarity to known gene
sequences through a combination of similarity information with signal information, and
while these methods are very good at identifying new genes similar to known genes, they
are limited when given a signal with no similarity information [1]. Several well-known
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tools implement a homology based approach to computational gene finding including
INFO, ICE, AAT, SYNCOD, EbEST, Est2genome, TAP, PAGAN, DIALIGN [1]. De
novo based annotation methods typically use signal information identified through the
use of Hidden Markov Models (HMMs) to predict genes, and a number of tools utilize
this approach including Genscan, Genie, GeneMark.hmm, and FGENESH [1]. Several
issues can affect the accuracy of these de novo prediction algorithms and give rise to
errors including large genes, large introns, highly conserved introns, small exons,
overlapping genes, polycistronic gene arrangement, frameshifts, and alternative splice
sites [1].
In addition to these traditional structural genome annotation methods, the use of
high throughput shotgun proteomics data derived from mass spectrometry experiments is
increasingly being used as a complementary method for structural genome annotation [4].
This use of proteomics data to aid in genome annotation was first reported in 2001 [5] for
several prokaryotic projects, and was popularized in 2004 by Jaffe et al., who coined the
term proteogenomic mapping [6]. Proteomic evidence, identified as expressed Protein
Sequence Tags (ePSTs), provides proof that a given gene is expressed, and when back
translated and aligned with the sequenced genome, provide structural annotation
information for a genome’s functional elements [4, 7]. This can include “confirmation of
translation, reading-frame determination, identification of gene and exon boundaries,
evidence for post translational processing, identification of splice-forms including
alternative splicing, and also, the prediction of completely novel genes” [4].
Proteogenomic mapping has been utilized in a number of both prokaryotic [5, 6, 8-14]
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and eukaryotic [15-26] genome annotation projects, and is increasingly becoming a part
of standard annotation pipelines utilizing multiple sources of evidence (sequenced nucleic
acids, computational gene prediction, and proteomics data) [2].

Prokaryotic Proteogenomic Mapping
Much prior work in proteogenomic mapping has been done in prokaryotic
genome annotation projects [5, 6, 8-14]. These prokaryotic genomes have relatively
simple genome structures compared to eukaroytic genomes. Unlike eukaryotes,
prokaryotes do not have an intron-exon gene structure nor are they subject to alternative
splicing [5]. In addition, these prokaryotic genomes are significantly smaller than
eukaryotic genomes, and this small genome size compared to that of eukaryotes allows
for direct searching of spectral databases made up of peptides generated from the genome
sequence translated in all six reading frames [5]. Table 5.1 shows a comparison of
genome sizes for selected prokaryotic and eukaryotic genomes.

Eukaryotic Proteogenomic Mapping
While eukaryotic proteogenomic mapping projects began shortly after their
prokaryotic counterparts [15-18, 20, 22, 23], the complications arising from the larger
and more complex genome structure has prevented proteogenomic mapping from
becoming a significant part of genome structural re-annotation projects in eukaryotes
until recently [19, 21, 24-26]. These differences in eukaryotic genome structure
compared to prokaryotic genomes arise from the intron-exon structure of genes, repetitive
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regions of the genome, gene duplications, splicing and alternative splicing events, and the
large areas of intergenic DNA [5].
A number of different approaches for constructing and searching databases of
peptide spectra have been developed to address the challenges of using proteomics for
genome annotation in eukaryotes. One of the simplest approaches is to search spectra
against the genome in its entirety or against selected chromosomes in the genome of
interest [15]. A modification of this method is to break the genomes into large chunks of
nucleotides with each chunk having some overlap regions with the adjacent chunks [17,
20, 23]. In 2005, Kalume identified 50 novel transcripts and one novel gene in Anopheles
gambiae (mosquito) using this method [23], while McCarthy (2006) used this method to
identify 521 potential novel proteins from the Gallus gallus (chicken) “unassigned
chromosome”. The “unassigned chromosome” represents 10-11% of the chicken genome
and is composed of sequences not mapped to the genome assembly [22]. In 2006,
Fermin generated a database composed of all ORFs from the Homo sapiens genome, and
utilized that for DB searches, identifying 282 significant ORFs with 627 novel peptides
[18]. In 2007, Tanner utilized computational gene prediction software to identify exons
within the Homo sapien genome and then constructed exon-splice graphs, which for a
given gene take the starting exon and construct sequences by mapping it to all possible
internal exons in order to represent alternative splice forms [21]. Using this method, they
identified 16 novel genes and extended exons, while confirming over 40 alternate
splicing events [21]. Some eukaryotic projects have used the de novo sequencing of
peptides instead of a database search, and then used these de novo identifications to
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search genome sequences with BLAST in order to identify regions that code for proteins
[16].
More recently, several of these approaches have been combined or coupled with
changes to spectral generation protocols by various research groups for more
comprehensive proteogenomic mappings [19, 24, 25]. In an application of
proteogenomic mapping to the Arabidopsis thaliana genome, Castellana (2008)
constructed three separate databases: the proteome database, a database comprised of
exon-splice graphs, and the genome translated in all six reading frames. Using this multidatabase approach, they identified 778 new protein coding genes and refined the
annotation of 695 gene models [19]. In a proteogenomic mapping project with
Caenorhabditis elegans , Merrihew (2008) constructed databases for the proteome,
predicted genes from a computational gene finder (GeneFinder) not contained within the
proteome database, and the intergenic regions that shared a high homology with
Caenorhabditis briggsae, a closely related species [25]. Searching against these
databases, they identified 429 new coding sequences not present in the known proteome,
33 of which were predicted pseudogenes and 245 of which were novel genes [25]. In
2008, Sevinsky combined isoelectric focusing of peptides subjected to mass spectrometry
with databases constructed from a six frame translation of each contig of the Homo
sapiens genome. These databases were in silico trypsin digested and the in silico
peptides were sorted by molecular weight (MW) and isoelectric point (pI) [24]. These
were further separated by splitting the in silico peptides into separate databases for every
0.01 pI interval. These were further separated into genic and intergenic databases [24].
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Experimental spectra from a given pI range were then searched against the corresponding
database, and this methodology yielded 540 genome specific peptides that had no
matches against the human proteome [24].

Gallus gallus Proteogenomic Mapping
The Gallus gallus (chicken) genome draft sequence was released in 2004, and is
approximately 1,200 Mbp with ~20,000 to 22,000 genes [27]. The most current build is
Build 2.1, released in November 2006, and has a 6.6X coverage with 95% of the genome
anchored to chromosomes. The chicken genome contains 38 pairs of autosomal
chromosomes and 2 sex chromosomes (Z and W) [27]. Of the 38 autosomal
chromosomes, 33 are classified as microchromosomes and these microchromosomes
have a very high gene density [28]. A large portion of the unsequenced genome resides
on the microchromosomes and this results in ~5-10% of the predicted chicken genes
being absent from the Ensembl gene set [27]. Chicken represents an important
agricultural species, has a long history as an important medical model, serves as the
avian model organism, and it is an important vertebrate outlier on phylogenetic trees
because of its evolutionary distance (~310 million years) from mammalian species [27].
While the build number of the chicken genome is low compared to that of human
and mouse, there are similar numbers of predicted proteins, but many fewer ESTs are
available to aid in the structural annotation. We have used mass spectra from chicken
serum to improve structural annotation of the chicken genome. We also address methods
for database organization to obtain a significant number of peptide spectra matches when
searching against databases derived from genetic sequences.
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Results and Discussion
Our initial proteogenomic mapping experiments with several previously published
chicken mass spectral datasets using a decoy database search strategy resulted in very
few peptides that were unique to the genome when spectra were identified using searches
against to the genomic database. Our decoy databases for the proteome and genome
were derived using Markov chains based on the chicken proteome and the chicken
genome respectively. Further investigation of the Δ CN and XCorr quality scores from
the Sequest searches against the proteome and genome revealed that there were many
high scoring peptide matches against the proteome, but very few high scoring matches
against the genome as illustrated in Figure 5.1. Similar results were obtained for a
chromosome relatively poor in serum protein genes (chr 6) and a chromosome relatively
rich in serum protein genes (chr 3). Therefore we investigated different database
construction approaches.
Since the size of the genome database is more than six times the size of the
proteome database, we conducted an experiment to determine if the loss in peptide
identifications against the genome was a function of database size. For this experiment,
the proteome database was concatenated with increasing amounts of decoy random
amino acid sequence to serve as the proteome database. Decoy databases of the same
size were also generated and these databases were used to search for PSMs. Figure 5.2
shows the effects of database size on the number of peptides identified. The number of
peptides identified against the proteome was used as a baseline and is indicated by zero
on the x-axis (zero added decoy sequence) and one on the y-axis. Decoy amino acid
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sequence was progressively added to the proteome in increments the same size as the
proteome. Thus, a value of two on the x-axis means that the database was three times as
large (proteome + 2x decoy) as the original proteome database.

We noted a significant

decrease in the peptide identifications as the number of spectra from decoy sequence
increased. As Figure 5.2 indicates, there is substantial difference in the loss of peptide
identifications among different datasets indicating differences in the quality of the mass
spectra. Because these poor quality spectra are not robust to the addition of noise, they
are not useful for proteogenomic mapping. This process of iteratively adding “noise” to
the proteome and conducting searches provides a method for determining if spectra are of
sufficiently high quality for proteogenomic mapping. As shown in Figure 5.2, the new
serum proteomics dataset used for this study (collected using updated methodologies and
equipment) is substantially more robust to the addition of noise than the older datasets.
The influence of database size on results obtained when searching against the
genomic sequences translated in 6 reading frames also led us to use separate databases for
genic and intragenic regions. In order to maintain a one-to-one relationship between the
number of proteins in our protein database and the number of genes in our genic
database, we constructed all three of our databases (proteomic, genic, and intragenic)
based on the chicken proteins in the International Protein Index (IPI) database, which
provides “minimally redundant yet maximally complete sets of proteins for featured
species” [29]. Our genic database was generated by locating the gene sequences
corresponding to proteins found in the IPI database, and extracting the DNA sequence
including introns plus 5’ and 3’ UTR sequence from the sequenced genome. Since the
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lengths of the 5’ and 3’ UTR sequences have not been determined experimentally for
most chicken genes, we used 5’ and 3’ UTR lengths based on the mean lengths for
Homo sapiens [30]). Peptides were identified using the Sequest spectral matching
algorithm [31] by searching against our three databases and validated using a targetdecoy database search strategy. Peptides with a p-value of less than 0.05 were considered
valid identifications. Peptides identified by searching against the genic or intergenic
databases but against the proteome database were analyzed with the Proteogenomic
Mapping Tool [32] to generate the reverse translated (RT) sequences for each of the
peptides by mapping each of these RT peptides back to locations within the chicken
genome.
Our searches against the IPI Gallus gallus proteome database identified 268
proteins comprising the serum proteome. These proteins were identified by 8,797
peptides (960 unique peptides). We also identified 2,993 peptides when searching
against our genic database. Of these 2,933 genic peptides, 2,742 were present in the
results of the proteome search, resulting in 251 peptides (represented by 48 unique
peptides) matching the genic database but not the proteome database. After examination
of these peptide sequences, we identified 4 peptides in this dataset which were digests of
peptides present in the results of the proteome DB search. This resulted in the
identification of 44 unique peptides that map to the genic database but not to the
proteome. Ten of these genic peptides were mapped into proteins identified by different
proteomic peptides through our search of the proteome database. Searches against the
database composed of intragenic regions yielded three unique peptides.
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The ten unique peptides identified from our genic database search that also have
corresponding evidence for expression from our proteome database search are shown
mapped to the genome in Figures 5.3 - 5.6. Figure 5.3 shows an instance where a peptide
maps to a chicken EST within the 5’ UTR of an IPI protein similar to α-2-macroglobulin
(IPI00599918) curated proteins on the same strand (aqua track). The peptide aligns with
the NCBI gene model for this protein, but not the Ensembl gene model. Since the IPI
proteins are heavily derived from the Ensembl gene models, this peptide was not present
in the proteome database we performed our proteome search against, but we did observe
several hits of different peptides against the proteome database for the IPI/Ensembl
model, indicating the NCBI model is more accurate. Figure 5.4 shows six peptides
mapping on the same strand to regions within the Immunoglobulin (IG) Lambda Chain
Variable-1 Region in a region of high translation expression.
Some of these peptides have no exon or EST evidence, and we hypothesize that we are
observing a sufficiently sensitive proteogenomic mapping to pick up the splicing changes
in the exons of IG variable regions as part of the synthesis of immunoglobulin. Figure
5.5 shows a single peptide mapping to the 5’ UTR of serum albumin (IPI00574195).
Many peptides matching the proteome database confirm the expression of serum
albumin. Given that this peptide is on the same strand as serum albumin, it is indicative
of a potential new exon or gene.. Figure 5.6 shows a peptide mapping to the same strand
as the 5’ UTR of an uncharacterized protein (IPI00821912) which we identified as
expressed through our searches of the proteome database. This peptide maps to a chicken
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EST in this region, providing proteomic evidence confirming expression of the EST, and
a possible correction of the annotation information for this uncharacterized protein.
The remaining 34 genic and 3 intragenic peptides can be divided into five groups
based on where they map within the genome:
1.
2.
3.
4.
5.

Peptide confirming protein expression
Peptide confirming exon from mRNA
Peptide indicating novel exon or gene
Peptide correcting exon boundary
Peptide in or near a repeat region

Figures 5.7 through 5.11 show examples of each of these groups. In Figure 5.7 two
reverse translated (RT) peptides not seen in the set of peptides identified with the
proteome database are shown. The genomic peptide IPI00579242 maps on the same
strand as a gene model present in both the NCBI/Ensembl gene sets confirming protein
expression, and providing evidence of a potential new exon within this protein. The
second genomic peptide, IPI00580765 is shown mapped into a region between two genes
in both the NCBI/Ensembl protein sets along the same strand indicative of a potential
new small gene or exon in this region. Figure 5.8a shows an RT peptide confirming an
NCBI gene where there is no Ensembl gene in the area and Figure 5.8b shows the same
peptide using the UCSC genome browser confirming multiple mRNA evidence for an
exon in the indicated region. Notably, the gene model from NCBI identified in a) is not
indicated as having a higher confidence RefSeq gene model by b), meaning there is not a
curated gene model for this gene in the NCBI database. Figure 5.9 a) shows 3 distinct
RT peptides mapping to a novel chicken exon or gene while b) shows the same three
peptides visualized with the UCSC genome browser in order to gain the conservation
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track. These peptides are shown to map to an area of high conservation, providing
evidence of a novel chicken exon or gene in this area. Figure 5.10 a) shows an RT
peptide expressed within a known gene model along the same strand, near an exon and
two repeat elements. Figure 5.10 b) shows this same peptide using the UCSC genome
browser clearly mapping to a repeat region within the genome identified by
RepeatMasker. Figure 5.11 a) shows an RT peptide that corrects an exon boundary in the
structural annotation of the chicken genome of an Ensembl gene. It maps to the same
strand to the edge of a known Ensembl gene, and b) shows that the peptide maps to a
region of conservation at the 3’ end of this gene model. There is no NCBI gene model
for this protein (IPI00595493).

Conclusions
We have confirmed the expression 268 serum proteins from our Gallus gallus
proteome database. The 47 remaining peptides that map uniquely to the genic and
intragenic regions of the Gallus gallus genome were used to improve the structural
annotation by confirming 2 exons predicted by mRNA, providing evidence of 17 novel
exons or genes, showing evidence of the expression of 7 repeat regions, and providing 4
corrections to the boundaries of known exons. These peptides serve as a complementary
method to traditional structural annotation methodologies, and for model organism
genomes like chicken, that do not undergo the same level of refinement as human or
mouse, provide annotation correction information that might not be otherwise readily
available.
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The use of proteogenomic mapping as a tool to aid in the structural annotation of
genomes shows that even the most up-to-date de novo or homology based computational
gene prediction misses or incorrectly annotates a number genes. Additionally,
proteogenomic mapping provides proof that a given protein is actually translated and
expressed in a tissue as opposed to the evidence of translation obtained using massively
parallel next-generation sequencing technologies. As mass spectrometry techniques
improve and the speed of matching spectra to peptides increases due to both improved
algorithms and increased computational power, proteogenomic mapping should be
increasingly utilized to provide and confirm structural annotations of eukaryotes.
Future work should focus on identifying areas of the genome where there is
discrepancy between the NCBI and Ensembl gene model datasets and identifying
peptides identified as expressed from those areas as part of an effort to improve
computational tools for gene prediction. Additionally, efforts to include peptides with a
lower probability of expression when identified using a decoy database strategy could be
incorporated by anchoring regions with high probability expression peptides and then
including lower probability peptides locally. Alternatively, our strategy of constructing
the genomic database based on the protein database and not searching raw genomic
sequence or performing extensive experimental manipulations allows regions were
protein expression is observed to be easily identified and potentially used for construction
of smaller databases supporting stepwise searches. When combined with an anchoring
method, this could potentially provide higher coverage of peptides to the genome from a
given experimental dataset.
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Methods and Materials

Mass Spectrometry Datasets
The initial Gallus gallus serum MS dataset used is described in [33] and the
Gallus gallus bursa MS dataset used for Figure 5.2 is described in [22]. For the updated
serum dataset, a new serum sample from a serum pathogen free broiler chicken was
taken.

Protein Isolation
Serum was collected from clotted whole chicken blood in inverted 3 cc/mL
syringes. Serum was aliquoted, clarified (1000 rpm, 5 min, 4 °C) and protein yield was
determined using the Pierce BCA Protein Assay Kit (Fisher Scientific, Pittsburgh, PA).
One-dimensional (1-D) gel electrophoresis was performed on serial dilutions of the
serum (1:2, 1:10, 1:25)(Criterion Gel System, Bio-Rad, Hercules, CA). Gels were
stained with Coomassie Blue (Processor Plus, Amersham Biosciences, Piscataway, NJ)
and documented (FluorChem SP, Alpha Innotech, San Leandro, CA).

Trypsin Digestion
In-gel and in-solution tryptic digestions on the serum were done in parallel for
protein coverage comparison (43.4 μg protein were used). Prior to in-gel tryptic
digestion, the lane representing the 1:10 dilution was selected and divided into 5
fractions: group 1 (darkest bands), group 2 (medium bands), group 3D (darkest light
areas between bands), group 3M (medium light areas) and group 3L (lightest light areas).
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Gel fractions were destained (50 mM NH4HCO3/50 % acetonitrile, 10 min), dehydrated
(100 % acetonitrile, 15 min), reduced (10 mM DTT 30 min), alkylated (55 mM
iodoacetamide, 20 min), dehydrated (100 % acetonitrile, 3 × 5 min), rehydrated (50 mM
NH4HCO3, 10 min) and trypsin-digested (10 µg, O/N, Promega, Madison, WI). All steps
were done at 35-37 °C. Peptides from the fractions were extracted (1% TFA, 2%
acetonitrile, 2 × 30 min; the second time with 100 % acetonitrile). For the in-solution
tryptic digestions, aliquots (10 μL) of the 1:10 dilution were reduced (5 mM DTT, 5 min,
65 °C), alkylated (10 mM iodoacetamide, 30 min, 37 °C) and trypsin-digested (1 μg,
O/N, 37 °C, Promega, Madison, WI). All in-gel and in-solution tryptic digests were
vacuum centrifuged until dried completely (Savant SPD2010, Thermo Electron, Milford,
MA) and resuspended in 0.1 % formic acid. Digests from groups 3D, 3M and 3L were
pooled, vacuum centrifuged and resuspended in 0.1 % formic acid.

Sample Cleanup
After digestion, samples are adjusted to 2% Acetonitrile and each is desalted
using a peptide macrotrap (Michrom TR1/25108/52) according the manufacturer’s
instructions. Following desalting, samples are cleaned using a strong cation exchange
(SCX) trap (Michrom TR1/25108/53) according to the manufacturer’s instructions to
remove detergents or other polymers which can interfere with MS/MS analysis. All
samples were then dried and resuspended in 20 µl of 5% Acetonitrile, 0.1% Formic Acid
and transferred to a low retention autosampler vial for deconvolution via reverse phase,
high pressure liquid chromatography.
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Nanospray LC/MS
Each sample was loaded on a BioBasic C18 reversed phase column (Thermo
72105-100266) and flushed for 20 min with 5% acetonitrile (ACN), 0.1% formic acid to
remove salts. Peptide separation was achieved using a Thermo Surveyor MS pump with
a 655 min nano-HPLC method consisting of a gradient from 5% ACN to 50% ACN in
620 min, followed by a 20 minute wash with 95% ACN and equilibration with 5% ACN
for 15 minutes (all solvents contain 0.1% formic acid as a proton source). Ionization of
peptides was achieved via nanospray ionization using a Thermo Finnigan nanospray
source type I operated at 1.85kV with 8 micrometer internal diameter silica tips (New
Objective FS360-75-8-N-20-C12). High voltage was applied using a t-connector with a
gold electrode in contact with the HPLC solvent. A Thermo LCQ DECA XP Plus ion
trap mass spectrometer was used to collect data over the 655 minute duration of each
HPLC run. Precursor mass scans were performed using repetitive MS scans, each
immediately followed by three MS/MS scans of the three most intense MS peaks.
Dynamic exclusion was enabled with a duration of two minutes and a repeat count of
two.
Protein Identification
Database searches were performed using the SEQUEST algorithm [34] in
Bioworks 3.3 (Thermo Finnigan). The proteome database for peptide spectral matching
was the Gallus gallus IPI protein database (version 3.56) [29]. Search results were
filtered using a decoy based, distance-based outlier detection method in which a
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probability of being a false positive match is assigned to each peptide [35]. The decoy
database was constructed using a 0th order hidden Markov model based on the amino acid
distribution of the proteome. Proteins with a probability of differential expression of 0.05
or less were selected for further modeling. Two different databases for peptide spectral
matching against the genome were constructed based on the Gallus gallus IPI protein
database (version 3.56). The first database contains the genetic sequences of all the
proteins contained within the IPI protein set including introns and 5’ and 3’ regulatory
regions [30], and the second database contains all the remaining intragenic regions not
contained in the first database. Decoy databases were constructed using a 5th order
hidden Markov model based on the nucleotide distribution in each of these two databases.
Proteogenomic Mapping
Custom Perl scripts were used to identify peptides with unique peptide spectral
matches to the genomic databases and these peptides were mapped onto the chicken
genome using the Proteogenomic Mapping Tool, a Java based tool which implements the
Aho-Corasick string mapping algorithm for proteogenomic mapping in both prokaryotes
and eukaryotes [32]. The resulting output was then visualized using Gbrowse [36, 37]
and the UCSC Genome Browser [38], and GFF3 files were also generated for use with
other genome browsers.
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TABLE 5.1
COMPARISION OF GENOME SIZES FOR SELECTED PROTEOGENOMIC
MAPPING PROJECTS

Organism
Channel catfish herpesvirus
(CCV)
Mycoplasma mobile
Mycoplasma pneumonia
Haemophilus influenzae
Porphyromonas gingivalis
Haemophilus somnus
Pasteurella multocida
Mannheimia haemolytica

Genome Size
(Mbp)

Reference
0.13
0.78
0.8
1.8
2.2
2.3
2.5
2.8

Geobacter lovleyi
Geobacter bemidjiensis
Yersinia pestis
Rhodopseudomonas
palustris
Arabodopsis thaliana
Caenorhabditis elegans
Tetrahymena thermophila
Anopheles gambiae
Gallus gallus
Danio rerio

[11]
[8]
[5]
[5]
[5]
[13]
[13]
[13]

3.9 [10]
4.6 [10]
4.7 [14]
5.5
~125
~100
~102
~278
~1500
~3112

[9]
[19]
[25]
[17]
[23]
[22]
[26]
[15, 18,
20, 21,
~3400 24]

Homo sapiens
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a)

b)

Figure 5.1
Initial Comparision of Peptide Spectra Matches Against the Proteome and Gallus gallus
Chromosome 6.
a) Gallus gallus Proteome Target-Decoy Analysis
b) Gallus gallus Chromosome 6 Target-Decoy Analysis
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Proportion of Peptides Identified
Relative to the Proteome DB

Effect of Database Size on Number of Peptides Identified
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0

Serum-2004
Bursa-2006
Serum-2011

0

1

3

5

13

Amount of Added Proteome Decoy Sequence Concatenated to
Proteome Target DB
Figure 5.2
Loss In Shared Peptide Identifications
Between Proteome and Databases of Increasing Size
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Figure 5.3
IPI00599918 – Similar to Alpha-2-Macroglobulin

Figure 5.4
IPI00582126 – IG Lambda Chain V-1 Region
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Figure 5.5
IPI00574195 – Serum Albumin

Figure 5.6
IPI00821912 – Uncharacterized Protein
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Figure 5.7
A Peptide Confirming Protein Expression and Possible Novel Exon and a Peptide
Representing Novel Exon or Gene
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a)

b)

Figure 5.8
Peptide Confirming Exon From mRNA
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a)

b)

Figure 5.9
Peptide Indicating Novel Exon or Gene
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a)

b)

Figure 5.10
Peptide In or Near a Repeat Region
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a)

b)

Figure 5.11
Peptide Correcting Exon Boundary
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CHAPTER VI
CONCLUSIONS

The increasing volumes of genomic, transcriptomic and proteomic data available
has resulted in the need for rapid analytical techniques that derive information from that
data. This dissertation addresses the application of machine learning algorithms to
proteomics problems. This chapter summarizes each project and evaluates the research
as a whole. We have shown that it is possible to predict experimentally observable
properties of peptides using machine learning classifiers and that the application of mass
spectrometry derived proteomics data can help improve the structural annotation of
genomes.

Prediction of Peptides Observable by Mass Spectrometry
Chapter II describes a procedure for constructing an artificial neural network
classifier to predict which tryptic peptides in a protein are likely to be detectable by mass
spectrometry for a specific set of experimental and instrumental conditions. We
demonstrate that it is possible to construct a classifier with accuracy comparable to those
previously reported based on the accumulation of large training sets from multiple
experiments. We also show that a classifier constructed based on one dataset does not
perform at an acceptable level when predicting observability for another dataset and thus
129

it is necessary to construct classifiers that are specific for one set of experimental
conditions. The resulting classifier provides researchers with a tool that can provide
information about peptide coverage of proteins in terms of which proteins are likely to be
detectable. It can also be used as one line of evidence in a systems analysis to evaluate
alternative hypotheses concerning proteins that were not observed but that were expected.
If the “missing” protein generates many predicted detectable peptides but none were
observed, then this provides additional probabilistic evidence of absence of the protein—
a very difficult hypothesis to demonstrate conclusively. The classifier allows researchers
to distinguish between proteins that are not likely to be detected with the methodology
versus proteins that were not expressed in the biological system and to thus improve
biological modeling.

Prediction of Cell Penetrating Peptides
We have identified sets of known cell penetrating peptides and non-penetrating
cell penetrating analogs from the literature and use these to construct a number of
different datasets to address the problem of imbalance between the number of positive
and negative examples. Utilizing these datasets, we show that it is possible to obtain a
higher than previously reported accuracy for the prediction of cell penetrating peptides
using support vector machines as opposed to previous methods utilizing a method based
on determining if the average score of a peptide falls within a range of features
determined through the use of principle component analysis. We then generate a number
of peptides based on the amino acid distribution of the chicken proteome and classify
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these peptides as either cell penetrating or non-cell penetrating based on the predictions
of our classifiers. These peptides along with positive and negative experimental controls
were synthesized and analyzed for cell penetration using two avian cell lines. Our
classifiers accurately predict cell-pentrating potential, and we have identified a lack of
negative examples of cell penetrating peptides in the literature. Additionally, we have
noted that the cell type being used for the evaluation of cell penetrating potential should
be included as a predictive feature in future studies as peptides previously predicted to be
penetrating or non-penetrating in previous studies using a specific cell line might not be
accurate for alternative cell lines.

Proteogenomic Mapping of Chicken Serum
We have confirmed the expression 268 serum proteins from our Gallus gallus
proteome database. The 47 remaining peptides that map uniquely to the genic and
intragenic regions of the Gallus gallus genome were used to improve the structural
annotation by confirming 2 exons predicted by mRNA, providing evidence of 17 novel
exons or genes, showing evidence of the expression of 7 repeat regions, and providing 4
corrections to the boundaries of known exons. These peptides serve as a complimentary
method to traditional structural annotation methodologies, and for model organism
genomes like chicken, that do not undergo the same level of refinement as human or
mouse, provide annotation correction information that might not be otherwise readily
available.
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The use of proteogenomic mapping as a tool to aid in the structural annotation of
genomes shows that even the most up-to-date de novo or homology based computational
gene prediction misses or incorrectly annotates a number genes. Additionally,
proteogenomic mapping serves provides proof that a given protein is actually translated
and expressed in a tissue as opposed to the evidence of translation obtained using 2nd
generation sequencing technologies. As mass spectrometry techniques improve and the
speed of matching spectra to peptides increases due to both improved algorithms and
increased computational power, proteogenomic mapping should be increasingly utilized
to provide and confirm structural annotations of eukaryotes.
Future work should focus on identifying areas of the genome where there is
discrepancy between the NCBI and Ensembl gene model datasets and identify any
peptides identified as expressed from those areas as part of an effort to improve
computational tools for gene prediction. Additionally, efforts to include peptides with a
lower probability of expression when identified using a decoy database strategy could be
incorporated by anchoring regions with high probability expression peptides and then
including lower probability peptides locally. Alternatively, our strategy of constructing
the genomic database based on the protein database and not searching raw genomic
sequence or performing extensive experimental manipulations allows regions where
protein expression is observed to be easily identified and potentially used for construction
of smaller databases to search against in a stepwise manner. When combined with an
anchoring method, this could potentially provide higher coverage of peptides to the
genome from a given experimental dataset.
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Summary
In Chapter II, we have shown that it is possible to predict the peptides observable
by mass spectrometry using neural networks for a single dataset in contrast to other
prediction methods utilizing large datasets compiled from a number of different
experimental techniques. Since the research presented in that chapter was conducted and
published, methods for statistically validating peptides from mass spectrometry derived
datasets have changed to provide a more statistical basis for determining which peptides
are valid hits against a target proteome database. Given these changes, future work in
predicting peptides observable by mass spectrometry could explore different strategies
for training dataset construction methodologies. Additionally, to obtain a better
understanding of which properties contribute to the prediction of flyability could be
obtained by analyzing the same proteomics mixture using a variety of digestion enzymes
in addition to trypsin while holding the LC-MS conditions constant. The entire database
of theoretical spectra could be analyzed to determine which peptides are proteotryptic,
reducing the size of the database to be searched against, and increasing the effectiveness
proteogenomic mapping for organisms with large genomes.
The research presented in Chapter III shows that machine learning algorithms
using individual biochemical properties for features instead of composite features derived
from principle component analysis can accurately predict whether or not a given peptide
is capable of cell penetration. The small amount of data available for constructing
training and testing datasets were discussed, and demonstrates the critical need for a
curated database of peptides shown to penetrate or not penetrate a given cell type.
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Additionally, future research should focus on compiling sets of non-penetrating analogs
of cell penetrating peptides to increase the number of difficult to predict negative
examples and to aid in the improvement of the prediction accuracy of classifiers.
Additionally, once individual cell types are included in the features used for prediction of
cell penetration, various features such the lipid composition of the cell membranes of
various cell lines could be included to aid in prediction and help provide better
understanding of the mechanism of cell penetration for that cell type.
Computational chemistry has provided software packages to analyze the
quantitative structure and activity relationships (QSAR) of molecules, and these QSAR
features were shown by Dobachev et al. [1] to aid in the prediction of cell penetrating
peptides, and could be combined with the basic biochemical properties we utilize for
features to improve the prediction accuracy of our classifiers for the prediction of flyable
peptides and cell penetration.
Chapter IV presents a tool for taking peptides observed via mass spectrometry and
mapping them back to the genome in a fast and accurate manner in order to help improve
the structural annotation of genomes. In Chapter V we utilize this method along with
various methods for assessing dataset quality and database construction to take peptides
observed from the serum of the domestic chicken and use them for proteogenomic
mapping to improve the structural annotation of the chicken genome. We show that
proteogenomic mapping is sufficiently sensitive to identify variations in splicing events
used to produce various immunoglobulin isoforms, and identify corrections to
intron/exon boundaries in predicted genes, and identify novel genes and exons not
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identified by traditional structural genome annotation methods. As more eukaryotic
proteogenomic mapping projects make progress, these novel genes, exons, and boundary
corrections should be incorporated in general gene models for improved gene predictions
and used for the correction of structural annotations in genomes.
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